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The present study aimed to accelerate and improve accuracy of ɣ-aminobutyric acid (GABA) and glutathione 
(GSH) quantification. These metabolites, present at low concentrations in the brain, are challenging to detect 
using MR spectroscopy due to the fact that their resonance frequencies overlap with those of other more 
abundant metabolites. The advanced spectral editing techniques involving J-difference editing that are required 
to resolve the overlapping signals of these low concentration metabolites are not routinely available on clinical 
MRI scanners.  
In this work we implemented on a 3T Siemens Skyra MRI a novel MRS technique called Hadamard Encoding and 
Reconstruction of MEGA-Edited Spectroscopy (HERMES) to simultaneously detect GABA and GSH, developed a 
novel postprocessing technique that simultaneously models the sum and various difference spectra, and 
evaluated the performance of the sequence and processing method both in phantoms and in vivo.     
HERMES was implemented by modifying the Siemens GABA-edited MEGA-PRESS WIP sequence to include two 
additional sub-experiments – one editing GSH with a single lobe pulse and one editing both GABA and GSH using 
a dual lobe pulse, and replacing the Siemens pulses with ‘universal’ pulses similar to those used in a previous 
implementation of HERMES on a Philips platform. Performance was assessed in a phantom and 22 healthy 
adults, 15 of whom provided usable data (7 male, mean age 25.6 ± 2.7 yr). Three of the subjects were scanned 
3 times to assess reproducibility.  
Data were processed and compared using a set of custom scripts in MATLAB. Following frequency and phase 
correction of individual averages with GANNET, we applied our custom simultaneous linear combination model 
that iteratively fit the concatenated sum and difference spectra using a least squares routine. SPM was used for 
tissue segmentation of structural images and FID-A to simulate high-resolution basis sets. The simultaneous 
modelling technique provided absolute quantification results for 15 metabolite moieties using internal 
unsuppressed water as a reference. The performance of the simultaneous fitting approach was compared to 
multiple independent fittings for HERCULES (Hadamard Editing Resolves Chemicals Using Linear-combination 
Estimation of Spectra) data that had been previously acquired on a 3T Philips Achieva MRI. 
Although the HERMES sequence implemented on the Siemens platform as part of this project was able to 
successfully edit both GABA and GSH, and generate line shapes consistent with the work by Saleh et al. (2016), 
quantification accuracy was disappointing. In the phantom data, GSH and GABA concentrations were both 
roughly 50% of known levels. Since the actual concentrations in vivo were not known, we were not able to 
establish accuracy, but quantification agreement between the MEGA-PRESS and HERMES sequences was poor 
for most metabolites. Specifically, GABA levels were two to three times higher than expected values using both 
HERMES and GABA-edited MEGA-PRESS. Despite poor absolute agreement, concentrations from HERMES and 
MEGA-PRESS data were moderately correlated, and HERMES data showed lower coefficients of variation across 
subjects, suggesting that it may be more reliable.  HERMES was also more reproducible across scanning sessions 
and participants for more metabolites than GABA- or GSH-edited MEGA-PRESS.  
Our findings also showed that simultaneous fitting using the sum and difference spectra produces lower 
coefficients of variation for most metabolites than fittings to sum and difference spectra separately. 
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1 
1 Introduction  
 
Magnetic resonance imaging (MRI) exploits the interactions that occur between different types of magnetic 
fields and an active element.  Active elements in the human body that can be imaged include hydrogen (1H), 
carbon (13C), sodium (23Na) and phosphorus (31P). However, due to the abundance of 1H in water in human 
tissues and its higher gyromagnetic ratio (ɤ) compared to other elements, 1H is the most commonly imaged 
element in MRI.  
While MRI is used to image 1H in water, magnetic resonance spectroscopy (MRS) allows direct detection and 
quantification of different endogenous metabolites containing 1H. Shielding by electrons of adjacent atoms 
causes small disturbances in the local B0 fields experienced by 1H nuclei in different chemical environments, 
resulting in shifts in the precessional frequency known as the chemical shift. Metabolites that are typically 
detected in the human brain include N-acetylaspartate (NAA), creatine (Cr), choline (Cho), myo-inositol (Ins), 
and glutamate (Glu) (de Graaf 2007). These metabolites can be robustly detected on clinical MRI scanners with 
field strengths of 3 T, due to their adequate concentrations in human brain and their well distinguished chemical 
shifts. Recently, there has been increasing interest in measuring γ-aminobutyric acid (GABA) and glutathione 
(GSH) levels in the brain. GABA is the chief inhibitory neurotransmitter in the brain and plays a role in the 
menstrual cycle, acute differentiation, visual light-dark adaptation, alcohol and substance abuse, epilepsy, 
depression, and panic disorders. GSH is a major anti-oxidant in the brain and alterations in levels have been 
linked to damage in myelin, oligodendrocytes and mitochondria, Parkinson’s Disease, Multiple Sclerosis (MS), 
and other neurodegenerative diseases.   
 
1.1 Problem Identification  
 
In vivo measurements of GABA and GSH are, however, challenging due to their low concentrations in the brain 
and the fact that their resonance frequencies overlap with those of other metabolites present in higher 
concentrations. As a result, GABA and GSH MRS require the application of advanced spectral editing techniques 
that are not routinely available on clinical MRI scanners.  
The first aim of this project was to implement on a 3 T Siemens Skyra scanner an MRS technique called Hadamard 
Encoding and Reconstruction of MEGA-Edited Spectroscopy (HERMES) for measuring simultaneously GABA and 
GSH levels of tissue noninvasively. HERMES utilises the J-coupling phenomenon of adjacent hydrogen atoms in 
a molecule with a technique known as J-difference editing. The technique allows for the differential phase 
evolution of a desired hydrogen atom by inverting the atom coupled to it with an editing RF pulse in a distinct 
region of the spectrum (i.e. at a different frequency). By comparing the edited spectrum to an unedited spectrum 
from the same voxel, one can determine the portion of the signal that was contributed by the coupled proton 
of interest. This technique is usually employed using the MEGA-PRESS sequence for a single metabolite at a time. 
HERMES builds on this by encoding two editing schemes simultaneously using an orthogonal Hadamard matrix, 
which allows the resolution of two low concentration metabolites simultaneously. Although this technique has 
previously been implemented on a Philips Intera 3 T scanner at the Johns Hopkins University, it has not been 
implemented previously on a Siemens platform.  
Historically, and particularly prior to 3 T scanners, clinical applications of MRS have been limited by poor 
sensitivity of metabolite quantification (Van Der Graaf 2010), especially for metabolites present in low 
concentrations. Although incorporating prior knowledge of the spin system evolution of different metabolites 
has improved the accuracy and stability of metabolite quantification from HERMES data, current approaches all 
consider difference spectra of specific metabolites in isolation. Here we implement a method that 
simultaneously models the sum and difference spectra of all metabolites and evaluate in vivo the reproducibility 




The objectives of the research are as follows: 
1. HERMES sequence development  
1.1. To modify the standard Siemens MEGA-PRESS pulse sequence (svs_edit work-in-progress (WIP) 
package) to perform HERMES acquisitions. This involves editing the source code of the pulse program 
and generating appropriate protocols. 
1.2. To standardise both pulse shapes and pulse timing to the Philips implementation as per Saleh et al. 
(2019). 
1.3. To install and validate the sequence on the 3T Siemens Skyra at the Cape Universities Body Imaging 
Centre (CUBIC) located at Groote Schuur Hospital adjacent to the UCT Faculty of Health Sciences.  
 
2. Develop a Simultaneous modelling technique  
2.1. To produce a complete basis set for the HERMES sequence of expected metabolite spectra using 
density matrix simulations.  
2.2. To develop a novel data processing technique in the MATLAB environment that incorporates prior 
knowledge and simultaneously models all data to quantify metabolite levels.  
 
3. Testing 
3.1. Compare spectral line shapes and quantification accuracy of HERMES and MEGA-PRESS acquisitions in 
phantoms. 
3.2. Compare HERMES and MEGA-PRESS line shapes and quantification in vivo.  
3.3. Assess quantification reproducibility in vivo.  
3.4. Compare performance of the simultaneous fitting routine to multiple separate fittings. 
  
1.3 Thesis Outline 
 
Following the general introduction in Chapter 1, Chapter 2 presents basic principles of MRI and MRS, as well as 
theory related specifically to editing and quantification of GABA and GSH. MRI pulse sequences are also 
introduced, including various design considerations.  
Chapter 3 reviews the current and relevant literature, followed by a description of the methods employed in 
Chapter 4.  Chapter 4 comprises three sections – the first describes the sequence development, the second the 
development of the simultaneous modelling tool, and the last the experiments performed to test performance 
of both the sequence and modelling tool.    
Chapter 5 presents the results in 4 sections – phantom tests, in vivo tests, assessment of reproducibility, and 
comparison of simultaneous fitting to separate independent fitting. Chapter 6 presents a discussion of the 
results and chapter 7 some final conclusions and recommendations for future work.  
  
3 
2 Background Theory 
 
Figure 2-1 shows a typical 1H MRS spectrum where signals from different metabolites are plotted as a function 
of their frequency shift relative to a reference frequency. The chemical shift in parts per million (ppm) is defined 
as  
𝐶ℎ𝑒𝑚𝑖𝑐𝑎𝑙 𝑠ℎ𝑖𝑓𝑡 (𝑝𝑝𝑚) =
𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦−𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦
𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦
 ×  106. 
The fact that the spectrum contains several metabolites in a small chemical shift range leads to considerable 
spectral overlap, impeding spectral peak assignment and quantification, especially of metabolites present in low 
concentrations. For example, the GABA peak at 1.9 ppm can only be distinguished from NAA using advanced 
editing pulse sequences such as MEGA-PRESS (Mescher-Garwood Point Resolved Spectroscopy) (Mullins et al. 
2014). Furthermore, GSH is extremely difficult to isolate due to its frequency overlap with glutamate, glutamine, 
GABA, Cr+PCr, aspartate, and NAA (Govindaraju et al. 2000), even at high magnetic field strengths such as 14 T. 
A significant drawback of MEGA-PRESS is that it usually only edits one metabolite at a time, and from a single 
brain region. Recently, the Hadamard Encoding and Reconstruction of MEGA-Edited Spectroscopy (HERMES) 
approach (Chan et al. 2016) was introduced, that separately edits more than one metabolite with overlapping 
signals within a single acquisition. 
HERMES typically achieves single volume localisation using Point Resolved Spectroscopy (PRESS) (Chan et al. 
2016) (Saleh et al. 2016), and water suppression with a vendor-specific water suppression scheme (in the case 
of Siemens this is an optimised CHESS scheme (Ernst & Hennig 1995)). Additionally, J-difference editing is 
implemented using MEGA (Terpstra et al. 2006), but is multiplexed for multiple metabolite signals using 
Hadamard Encoding. These concepts are described in greater detail in the following sections.  
 
Figure 2-1 - 1H-MRS spectrum acquired at 3T from the left temporal lobe of a healthy adult (Ford & Crewther 2016). The Y-
axis gives the signal amplitude at different chemical shifts, and the integrated areas under specific peaks give the relative 
concentrations of said metabolites.  
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2.1 Properties of GABA and GSH  
 
2.1.1 γ-Aminobutyric acid (GABA) 
GABA (γ-aminobutyric acid) is the chief inhibitory neurotransmitter in the brain. Figure 2-2 shows its chemical 
structure and MR spectrum. GABA has six observable protons. At 3T field strengths, triplet resonances are 
observable at 3.01 and 2.28 ppm, while a quintet is observable at 1.9 ppm (de Graaf 2007). 
 
Figure 2-2 - The magnetic signature of GABA obtained from simulation (de Graaf 2007) 
 
2.1.2 Glutathione (GSH) 
GSH is a major antioxidant in the brain. Figure 2-3 shows its chemical structure and MR spectrum. Glutathione 
has a singlet at 3.77 ppm, two separate multiplets at 2.15 and 2.55 ppm, and three doublet-of-doublets at 2.93, 
2.98, and 4.56 ppm. 
 
 
Figure 2-3 - The magnetic signature of GSH obtained from simulation (de Graaf 2007) 
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GABA and GSH are both considered low concentration metabolites, with concentrations ranging from 1.3 to 1.9 
mM for GABA and 2 mM for GSH. Their signals overlap with the stronger creatine peak at 3 ppm, with creatine 
concentrations typically ranging from 5.1 to 10.6 mM, depending on the brain tissue type (Govindaraju et al. 
2000). Since both GABA and GSH have coupled 1H nuclei with split peaks, they can be isolated using J-difference 
editing. Although several sequences have been proposed to detect GABA, including 2D H NMR spectroscopy 
(Ryner et al. 1995a), double Band Selective Inversion with Gradient Dephasing (double BASING) (Star-Lack et al. 
1998), and double-quantum filter experiments (Mclean et al. 2002), the most commonly used is the MEGA-
PRESS sequence (Mescher et al. 1998). HERMES implements a multiplexed experiment that can be thought of 
as two simultaneous MEGA-PRESS acquisitions. Both HERMES and MEGA-PRESS are single voxel spectroscopy 
(SVS) techniques.  
 
2.2 Single Voxel Spectroscopy (SVS) 
 
Single voxel spectroscopy (SVS) acquires signal from a single region of space, typically with a volume ranging 
from 1 to 8 ml. Various methods have been developed to localise the signal during SVS, including Stimulated 
Echo Acquisition Mode (STEAM) (Frahm et al. 1987), Point Resolved Spectroscopy (PRESS) (Bottomley 1987), 
Localization by Adiabatic Selective Refocussing (LASER) (Garwood & Delabarre 2001), and Spin Echo Full Intensity 
Acquired Localised Spectroscopy (SPECIAL) (Fuchs et al. 2013). While the use of 6 adiabatic full-passage (AFP) 
pulses by LASER improves spatial localisation, this comes at the cost of longer echo times compared to PRESS 
and STEAM (de Graaf 2007). In the current work, we use PRESS localisation due to its higher signal to noise ratio 
compared to STEAM, and the fact that it is the technique employed in the MEGA-PRESS WIP we were adapting. 
PRESS excites the 1H nuclei using a slice selective 90° RF pulse, followed by two 180° RF pulses that are selective 
for mutually orthogonal slices, and crusher gradients between the RF pulses. PRESS has the advantage that it 
recovers the full available magnetisation and achieves reasonably fast echo times (TE < 35 ms) (Blüml & 
Panigrahy 2013). Figure 2-4 shows the generic PRESS pulse sequence. 
 
 
Figure 2-4 – PRESS pulse sequence showing three radiofrequency pulses and gradient pulses in the x, y, and z directions (de 
Graaf 2007) 
 
A key scanner detail that impacts the quality of the MR spectrum obtained is shimming. Shimming is the process 
of correcting inhomogeneities in the B0 field. All scanners undergo passive shim correction during 
commissioning, which corrects some zero- and first-order inhomogeneities. In addition, most scanners feature 
active shimming with dedicated shim coils, similar to the gradient coils, which allow for small adjustments to the 
field following the acquisition of a field map. Second-order shim correction is standard on Siemens Skyra and 
Prisma scanners, while this is an option on Siemens Vida scanners. Figure 2-5 illustrates the difference between 
first- and second-order shim fields. 
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Figure 2-5 - Illustration of 1st and 2nd order shim fields, with gradient coil generalised geometry adapted from (Wendt 2000) 
 
Using the shim coils, the equation representing the corrected B0 field becomes 
𝐵0𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 =  𝐵0𝑢𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 +  𝐴11𝑥 + 𝐴12𝑦 + 𝐴13𝑧 + 𝐴21𝑧
2 + 𝐴22𝑧𝑦 + 𝐴23𝑧𝑥 + 𝐴24𝑥𝑦 + 𝐴25(𝑥
2 − 𝑦2), 
where A11, A12 and A13 are three linear/1st order coefficients, and the remaining five are second-order 
coefficients. If there were 3rd order correction, an additional five terms would be required. Using the shim coils, 
most MRI scanners automatically perform manual shimming before the start of a spectroscopy acquisition. Once 
the field maps have been generated, the scanner records the full width half maximum (FWHM) (Figure 2-6) of 
the water peak and prompts the user to accept or reject the shim.  
 
 
Figure 2-6 - Generalised illustration of the Full Width Half Maximum (FWHM) of a signal (Nordmann 2007) 
 
The water FWHM is a useful measure of field homogeneity, as water protons should in a perfectly 
homogeneous field all precess at the same frequency due to the absence of local shielding effects. As such, any 




2.2.1 Water Suppression in MRS 
 
The most abundant molecule in brain tissue is water. Hydrogen nuclei in water generate an MRI signal at 4.7 
ppm relative to Tetramethylsilane (TMS) that is three orders of magnitude larger than the signal from most other 
hydrogen-containing metabolites (Figure 2-7). Vibration induced signal modulations of this signal cause 
sidebands to the water peak that also distort the surrounding spectrum (de Graaf 2007). As such, accurate 
quantification of other metabolite concentrations requires that the water signal be suppressed.  
Methods for water suppression include binomial pulse sequences (Sklenar & Starcuk 1982), frequency selective 
refocussing such as MEGA (Mescher et al. 1996), relaxation-based methods such as WET (Water Suppression 
Enhanced through T1 effects) (Ogg et al. 1994), and frequency selective excitation methods such as Chemical 
Shift Selective Saturation (CHESS) (Haase et al. 1985),  SWAMP (Suppression of Water and Adiabatic-Modulated 
Pulses) (de Graaf & Nicolay 1998), and VAPOR (Variable Power Radiofrequency Pulses with Optimised Relaxation 
Delays) (Tkáč et al. 1999). SWAMP and VAPOR are variations of CHESS that have been optimised for different 
applications. All CHESS-based methods involve selectively exciting and then dephasing with crusher gradients 
the water signal prior to the MRS acquisition. Different MRI vendors employ different water suppression 
techniques. Siemens uses a three pulse optimised CHESS scheme referred to as ‘Strong Water Suppression’. 
 
 
Figure 2-7 – MRS spectrum of brain tissue; A) spectrum with unsuppressed water signal scale x1, B) spectrum with 
unsuppressed water signal scale x5000 showing sidebands, C) spectrum with water signal suppressed scale x5000 (de Graaf 
2007). 
 
2.2.2 Spectral Editing  
 
Spectral editing is the technique implemented to separate overlapped metabolites. Spectral editing utilizes 




2.2.3 J-coupling (scalar coupling)  
 
Energy states of nuclei depend on their quantised angular momentum. Since the spin quantum number (S) of a 
1H nucleus is ½, its nuclear spin is aligned either parallel (lower energy alpha () state) or antiparallel (higher 
energy beta () state) to the external magnetic field and its spectral peak corresponds to the characteristic 
frequency of the energy difference between the  and  states. In an isolated atom, the Fermi contact 
energetically favours an antiparallel orientation between nuclear and electronic spins. As such, the electron spin 
will be aligned antiparallel to the nuclear spin. 
However, when the proton is covalently bonded to another atom (I) also with nuclear spin ½, it is possible for 
the nuclear spins of both atoms to be aligned either antiparallel () or parallel () to the external magnetic 
field. In such situations, the Pauli exclusion principle dictates that the two bonding electrons have to be 
antiparallel to each other and as such cannot both be antiparallel to the nuclear spins as well. This forces one of 
the two nuclear-electronic spin pairs to be parallel, which is energetically less favourable, thus slightly increasing 
the energy levels of the  and  states of the two-spin system by an amount proportional to the scalar 
coupling constant (JIS). In contrast, when the nuclear spins of the two species are antiparallel to each other (i.e. 
the  and  states), the electron spins of both species can be antiparallel to their respective nuclear spins and 
still be antiparallel to each other. Since this is energetically favourable, the corresponding energy levels of the 
two-spin system are decreased by an amount equal to the energy increase of the  and  states. As such, for 
the S nucleus in the two-spin system, the energy difference between the  and  states is now increased or 
decreased by half the value of JIS depending on whether nuclear spin I is, respectively, antiparallel () or parallel 
() to the external field. The energy differences are illustrated in Figure 2-8.  
 
 
Figure 2-8 - A) The energy difference between nuclear spins aligned parallel (lower energy α state) and antiparallel (higher 
energy β state) to the external magnetic field (pointing vertically up in this example) is proportional to the precessional 
frequency of the nucleus. In this case, of an isolated S-spin, the electron and nuclear spins will be antiparallel. B) The four 
combinations of a weakly coupled IS spin system. For the ββ and αα combinations, the nuclear and electron spins of the I-spin 
are parallel (highlighted in red), which is energetically less favourable thus slightly increasing the energy levels of these states. 
In contrast, for the  and  states, the electron and nuclear spins of both nuclei I and S are anti-parallel, thus lowering the 
energy levels corresponding to these states. These changes alter the energy that is released when nuclear transitions occur, 
depending on whether the nucleus under consideration (I or S) is coupled with a nucleus that is in a β (giving a slightly higher 
frequency/left shift) or α (giving a slightly lower frequency/right shift) state. 
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The spectral peak of nucleus I (or S) is therefore divided into two peaks of equal intensity separated by JIS (Figure 
2-9). These splittings that arise from magnetic interactions between electron and nuclear spins are termed scalar 
or J-J couplings. 
Two peaks of equal intensity, however, only arise when the difference between the resonance frequencies of 
the two nuclear species I and S is much greater than the scalar coupling between them. This is typically true for 
heteronuclear couplings and in such cases the spin system is said to be weakly coupled. For homonuclear 
interactions, the frequency difference may be similar to the scalar coupling constant giving rise to strongly 
coupled spin systems. The  and  spin states now become mixed resulting in more complicated spectra with 
higher order effects.  
 
  
Figure 2-9 – Figure illustrating the I-spectrum of an uncoupled and weakly coupled IS system. The splitting of the peak to 
form a doublet can be seen in the coupled spectrum. 
 
2.2.4 J-difference editing using MEGA 
 
MEGA is a frequency selective refocusing method, originally used as a water suppression technique (Mescher 
et al. 1996), that employs J-difference editing to distinguish coupled peaks from overlapping uncoupled peaks 
in an MRS spectrum. MEGA features one sub-experiment (OFF) with a 90 degree excitation and a frequency-
nonselective 180 degree refocusing pulse (i.e. a normal spin echo experiment) (top row Figure 2-10A), and a 
second sub-experiment (ON) with two 180 degree pulses selective for the S spin inserted symmetrically around 
the frequency-nonselective refocussing pulse — one mid-way between the excitation RF and frequency-
nonselective refocusing pulse and the other between the refocusing pulse and acquisition (Figure 2-10A, 
bottom row).  
In the latter acquisition, the selective 180 degree pulses invert the S spin population only. For coupled spins, 
this will cause slower rotating I spins attached to S spins in the -state before the 180 degree pulse to become 
faster rotating I spins attached to S spins in the -state after the selective 180 degree pulse, and vice versa. 
Since the selective 180 degree pulse only inverts the sense of rotation of the coupled I spin but does not reset 
its phase, the I-spin coherences will be perfectly refocused at TE/2. As such the two different I-spin populations 
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of a coupled two-spin system will be completely in-phase at TE/2 when the frequency-nonselective refocusing 
pulse is applied, and again at TE when the signal is acquired. It is worth noting here that the evolution of 
coupling during TE is fully refocussed, thus maximizing editing efficiency, when the two editing pulses are 
separated by TE/2. In the presence of the two selective 180 degree RF pulses, the coupled I spins are therefore 
in-phase with each other at TE, as well as resonances from uncoupled spins (Figure 2-10B, bottom row). The 
modulation of the I-spin signal (and the signal from uncoupled spins) is therefore given by   
𝐼𝑦𝑒
−𝑇𝐸/𝑇2, 
where Iy is the component of the thermal equilibrium magnetisation of spin I (Iz) that was flipped by the RF 
pulse into the transverse plane. 
In contrast, during the spin echo acquisition, the two I-spin populations of a coupled two-spin system will 
acquire a net phase shift relative to uncoupled spins that depends on the echo time TE. This is due to the fact 
that the frequency-nonselective 180 degree refocusing pulse inverts both the acquired phases of the I spins 
and the S-spin population. While resetting the acquired phase of an uncoupled spin population results in the 
spin population being back in-phase at TE, the fact that the sense of rotation is also inverted for I spins coupled 
to S spins, causes the two I-spin populations (one coupled to S spins in the -state and the other to S spins in 
the -state) to acquire a net phase difference relative to each other, as well as a phase shift relative to 




𝑇2 ,  
where JIS is the scalar coupling constant. Notably, for TE = 1/JIS, the two I-spin populations will be in-phase with 
each other, but 180 degrees out-of-phase with resonances from uncoupled spins (Figure 2-10B, top row).  
Subtraction of the spectra with the coupled spins being in-phase and out-of-phase allow the coupled spins to 
be observed, while adding the two spectra give the uncoupled resonances. In this way, the signals from 
coupled spins (such as GABA and GSH) that are hidden by larger uncoupled signals can be isolated. In the case 




Figure 2-10 – Illustration of J-difference editing for resolution of an I-spin weakly coupled to an S-spin. A) The two RF pulse 
sequences. The top sequence is the ‘EDIT OFF’ sequence where no frequency selective editing pulses are applied. The 
bottom sequence is the ‘EDIT ON’ sequence where a pair of frequency selective editing pulses are added. B) The acquired 
spectra from both sequences. The dotted line shows the signal of the coupled I-spins. For the ‘EDIT OFF’ acquisition, the I-
spins are out-of-phase with uncoupled spins, while they are in phase for the ‘EDIT ON’ acquisition. 
 
MEGA-PRESS (Mescher et al. 1998) is a spatial localisation variation of MEGA, which features an additional 180 
degree refocussing pulse. Figure 2-11 shows the MEGA and MEGA-PRESS sequences. Timing details will be 





Figure 2-11 - Figure illustrating the generalised MEGA and MEGA-PRESS sequences. 
 
2.2.5 Hadamard Encoding and Reconstruction of MEGA-Edited Spectroscopy (HERMES) 
 
Hadamard encoding is a technique that is typically used for simultaneous multivoxel localization, such as for 
instance when spectra need to be acquired from n different slices. Essentially, the acquisition is repeated across 
the volume containing the n slices, n times – each time with the signals from different slices being selectively 
inverted. For instance, for four spatial slices, all four slices are acquired with the same phase in the first 
experiment, the last two slices are selectively inverted in the second experiment, the 2nd and 4th slices are 











in which +1 and -1 denotes no inversion and selective inversion, respectively. Multiplying the four separately 
acquired spectra with the Hadamard matrix (which is equivalent to adding and subtracting different 
combinations of the spectra from the four experiments), allows the spectra from the individual slices to be 
reconstructed. Specifically  
𝐻𝑛𝐻𝑛
𝑇 = 𝑛𝐼𝑛, 
where H is the Hadamard encoding matrix, I is the identity matrix, and n is the size of the matrix. 
Hadamard encoding was first combined with spectral editing techniques to simultaneously quantify N-acetyl 
aspartate (NAA) and N-acetyl aspartyl glutamate (NAAG) by Chan et al. (Chan et al. 2016). Saleh et al (2016) 
subsequently used HERMES to simultaneously quantify GABA and GSH. When employing the Hadamard 
encoding matrix to distinguish signals from two different separately-coupled molecules J and K, four separate 
sub-acquisitions are performed. In the first, selective refocusing pulses (editing pulses) are applied at the 




both the J and K spins at TE are in-phase with that from other non-coupled metabolites. In the second 
acquisition, editing pulses are applied only at the frequency of the spins coupled to the J molecule. This causes 
the resonances from the two J-spin populations to be in phase with uncoupled resonances, while those of the 
coupled molecule K will be out of phase. The 3rd acquisition has editing pulses applied only at the frequency of 
the spin system coupled to the K molecule, and the last acquisition has no editing pulses applied (Figure 2-12).  
 
 
Figure 2-12 - Figure showing the HERMES Hadamard encoding matrix for two coupled molecules with overlapping signal for 
one of their spins. Reproduced from Chan et al. (2016). 
 
The signals from either molecule J or K can then be isolated by adding the two ON-scans and subtracting the two 
OFF-scans of that molecule, i.e.   
𝑆𝑖𝑔𝑛𝑎𝑙𝐽 = 𝐴 + 𝐵 − 𝐶 − 𝐷 
𝑆𝑖𝑔𝑛𝑎𝑙𝐾 = 𝐴 − 𝐵 + 𝐶 − 𝐷 
Note that when editing for J as shown above, the K signal experiences 𝑂𝑁 + 𝑂𝐹𝐹 − 𝑂𝑁 − 𝑂𝐹𝐹, and therefore 
none of signal K is expected i.e. columns in the Hadamard matrix are orthogonal. This can be generalised by; 
𝑀 = 𝐻𝑇 × 𝑁, 
where M is a vector of the reconstructed spectra (dimension 2), H is the Hadamard matrix (dimension 4x2), and 
N is the vector of the recorded spectra (dimension 4). 
 
2.2.6 Hadamard Editing Resolves Chemicals Using Linear-combination Estimation of Spectra 
(HERCULES) 
 
HERCULES is an adapted version of the GABA and GSH edited HERMES sequence, which applies editing pulses at 
1.9 and 4.56 ppm for GABA and GSH, respectively. It features an additional editing pulse at 4.18 ppm in the two 
GSH OFF sub-experiments. This is intended to provide additional differentiation of the signals of NAA and NAAG. 




Figure 2-13 – The editing pulse scheme of the four HERMES and HERCULES sub-experiments. The solid lines show the 
frequency profile of the editing pulses applied in HERMES. In HERCULES editing pulses are applied at the frequencies shown 
by both the solid and the dashed lines (i.e. including the additional pulses at 4.18 ppm in the GSH “Off” experiments) 
(Oeltzschner et al. 2019).  
 
 
2.3 Pulse Sequences 
  
An MRI/MRS pulse sequence diagram is a simple way of showing how the radiofrequency (RF), for excitation, 
and magnetic field gradients, for spatial encoding, are applied during an MRI experiment. The vertical axis 
represents amplitude for each type of event and the horizontal axis time. Sequence development involves 
altering an existing sequence or building one from scratch using manufacturer functions, to perform an MR 
experiment that differs from available commercial sequences or work-in-progress sequences (WIPs). The 
sections below describe some of the elements of pulse sequences that required modification as part of the 
current project.  
 
2.3.1 Siemens Integrated Development Environment for Applications (IDEA) 
 
15 
While much of the source code for the various MRI manufacturers is 
protected trade secrets, the big four MRI manufacturers (Siemens, Philips, 
GE, Toshiba/Canon) all provide certain portions of their source codes to 
partner institutions under research agreements. UCT has a master research 
agreement with Siemens, which allows the sharing of limited source code on 
a project by project basis. Siemens regularly updates the scanner software 
and releases new versions when updates are substantially different. Siemens 
scanner software is traded under the name ‘syngo MR’. Currently installed 
on the Skyra at UCT (and the latest version) is VE11C. Sequences can be 
visualised, edited, and compiled using Siemens Integrated Development 
Environment for Applications (IDEA), which is also distributed under the 
master research agreement.  
IDEA is distributed with an extensive User Manual which provides guidance 
on the use of functions within the environment for debugging and testing 
sequences, and for compiling binaries for scanner installation. Syngo MR 
version is an important detail when it comes to sharing sequences between 
research sites.  
The following table shows the version numbers and scanners of institutions 
collaborating on this research;  
 
Table 2-1 - List of collaborating universities for this research, along with scanner hardware and software details 
Scanning centre Affiliated university Scanner model Software version 
CUBIC University of Cape Town Skyra 3T VE11C 
The Centre for Molecular Imaging 
(CTMI) 
The Johns Hopkins University Prisma 3T VE11B 
 
Siemens sequences are written in the C++ object orientated programming language. Sequences are built using 
Siemens functions (often closed source) and usually build on previous sequences. Siemens has a commercial 
PRESS sequence, under the trade name ‘svs_se’. There is a MEGA-PRESS WIP, under the trade name ‘svs_edit’, 
where interleaved editing pulses have been added. This WIP sequence is available to research institutions doing 
editing research (most commonly GABA editing). Due to the limitations of the sequence preparation protocol, 
the editing pulse file plays out in each measurement, and not only in the EDIT ON measurements as required. 
To overcome this, the svs_edit WIP applies the pulse in the OFF measurement at 7.5 ppm. At this frequency 
there are no coupled signals in the metabolite range so that the spectra are comparable to a measurement with 
no editing pulses. Figure 2-15 shows two sequential measurements of the svs_edit sequence. Although the two 
measurements appear identical, the editing pulses are tuned to different frequency bands according to the 
scheme described in the HERMES section previously.   
Figure 2-14 - Siemens Integrated 
Development Environment for 





Figure 2-15 - Two sequential acquisitions using svs_edit (MEGA-PRESS) and zoomed in annotated section showing the water 
suppression and editing pulses. Despite appearing identical, the editing pulses of the two measurements are tuned to different 
frequencies.  
 
2.3.2 RF pulses 
 
Nuclear spins are excited during an NMR experiment by briefly applying a radiofrequency (RF) pulse at the 
Larmor frequency in a coil perpendicular to the main magnetic field. This pulse gives rise to a time-varying 
orthogonal magnetic field denoted, in general, by B1. Since an alternating field is made up of two counter-
rotating fields, one of which will rotate at the same speed and in the same direction as the nuclear spins precess, 
the B1 field can be fixed to a reference frame (x’, y’, and z’) rotating at the Larmor precession frequency of the 
nucleus. The following graphs in this document (and in general in MR literature) show how the magnitude of the 
B1 field varies in the rotating reference frame. Two considerations for RF pulses are the frequency and phase 
response profiles. Pulses can either uniformly excite all frequencies in the NMR spectrum (like excitation and 
frequency-nonselective refocussing pulses) or excite limited frequency ranges (like water suppression and 
editing pulses).  
Pulse response can be calculated using either Fourier Transform Theory, the Bloch Equations, or optimisation 
procedures. Fourier Transform theory is most commonly used but does not accurately calculate off-resonance 
responses since it is a linear operation i.e. 𝐹𝑇(𝛼) + 𝐹𝑇(𝛽) = 𝐹𝑇(𝛼 + 𝛽), while NMR signal excitation is non-
linear i.e. 𝑀𝑥𝑦(𝜃1) + 𝑀𝑥𝑦(𝜃2) ≠ 𝑀𝑥𝑦(𝜃1 + 𝜃2). However, since at excitation angles less than 30° 𝑠𝑖𝑛𝜃 ≈ 𝜃, 
Fourier Transform Theory provides reasonable predictions for small excitation angles. Some of the most widely 
used RF pulse classes are described below. 
 
Sinc pulses  











giving the profiles shown in Figure 2-16.  
 
Figure 2-16 - Normalised (blue) and non-normalised (red) sinc functions (Johann 2011) 
 
For application in NMR this is scaled by the desired B1 field strength and separated into lobe number (n) and 
pulse duration (T). Notably, pulse duration defines the truncation of the pulse too since a sinc function 















The frequency domain representation of the above sinc pulse is shown in Figure 2-17 for 30°, 90°, and 180° 
rotations at resonance. 
 
Figure 2-17 - Magnetisation response of a sinc pulse for 30°, 90°, and 180° rotations at resonance as determined by the 
Bloch Equations (de Graaf 2007) 
 
Gaussian pulses  
Gaussian RF pulses are typically used for MRS editing and water suppression. They are convenient to work with 







  for  −𝑇/2 ≤ 𝑡 ≤ 𝑇/2, 
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), and  
B1max is the maximum strength of the field. β is defined as the truncation percentage and depends on the pulse 
length T. Figure 2-18 shows a typical inversion pulse and its magnetisation response. 
 
Figure 2-18 – Magnetisation response of a Gaussian inversion pulse for 1% and 10% truncation of the asymptotic time domain 
profile (de Graaf 2007). 
 
Multifrequency pulses  
HERMES and MEGA-PRESS require multifrequency editing pulses. These can be generated by simple addition of 
two complex pulse profiles. Separation of frequency selection is an issue if separation between editing 
frequencies is less than 4kHz.  
Asymmetric pulses  
As an alternative to a sinc pulse for excitation, one can truncate the second half of a sinc pulse more than the 
first, making it asymmetric. Asymmetric pulses have a more uniform excitation profile and allow shorter echo 
times (because most of the flipped magnetisation is near the end of the pulse) than symmetric sinc pulses (Stagg 
& Rothman 2013). However, they have the disadvantage that the high frequency modulation is present for all 
echo times, whereas for symmetric pulses this can be avoided by optimisation (de Graaf 2007). Figure 2-19 
shows the frequency response of a Gaussian pulse, and both symmetric and asymmetric sinc pulses. 
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Figure 2-19 - Magnetisation responses of Gaussian (A), Sinc (B), and Asymmetric (C) excitation pulses (Stagg & Rothman 
2013). 
R Value 
An important parameter that is useful in pulse design is the R value, which remains constant for a given RF pulse 
and nutation angle, and is defined as 
𝑅 = 𝑇 × ∆𝑤, 
where T is the pulse length and Δw is the bandwidth of the resultant magnetisation measured either at Mxy for 
excitation or Mz for inversion.  
 
2.3.3 Sequence timing 
 
Spin echoes occur at a time after refocusing that is equal to the time between excitation and refocusing, as this 
is when the spin system reaches maximum phase coherence. Figure 2-20 illustrates the timing of the echoes in 
a case where there are two refocusing pulses, such as in the PRESS sequence. 
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Figure 2-20 - RF pulses and echo timing for the PRESS sequence. 
 
For the timings TE1 and TE2 as defined in Figure 2-20, the total echo time (TE) for the PRESS sequence is given 
by 
𝑇𝐸 = 𝑇𝐸1 + 𝑇𝐸2. 
Furthermore, the time between the two refocussing pulses (Ref) equals half the total TE, i.e. 










For edited spectroscopy, two additional frequency selective refocussing pulses are applied – one between the 
first and second refocussing pulses, and another between the second refocussing pulse and the second echo 
(Figure 2-21).  
 
 
Figure 2-21 - RF pulses and echo timing for the MEGA-PRESS or HERMES sequences 
 
As mentioned previously, coupling evolution during TE will only be completely refocussed if the time between 









However, since this limits the maximum duration of the editing pulses, it is common to place the first editing 
pulse equally between the two refocussing pulses, and to place the second editing pulse equally between the 
























This timing, where the editing pulses are not symmetric about the second refocussing pulse and are not 
separated by TE/2, results in sub-optimal editing efficiency.  
 
2.4 Post-processing of MRS data 
 
The following sections aim to briefly introduce some of the key concepts related to post-processing of the signal 
acquired during an SVS acquisition, and two widely used packages for modelling MRS data. Although most 
vendors include processing on the scanner platforms, offline processing is more common.  
 
Averaging, frequency and phase correction 
Typically, the MRS signal is acquired repeatedly, once per ADC (analogue to digital conversion) event, and then 
averaged to improve the signal to noise ratio (SNR). The number of measurements is usually a multiple of four 
to allow for phase cycling (explained below), with edited protocols generally needing more measurements (e.g. 
320) than unedited protocols (e.g. 64).  
Due to the finite time (up to 10 minutes) required for a complete acquisition, the physical conditions of the voxel 
may, however, change between measurements. Frequency and phase correction are therefore performed 
routinely to correct changes in the precessional frequencies and phases between individual measurements that 
may arise from drift, changes in the local B0 field, and motion.  
 
Baseline correction 
While the signals from the metabolites of interest are sharp resonances in the frequency domain spectrum, 
these are superimposed on broader resonances from other elements. Baseline correction involves subtracting 
from the spectrum either a straight line or spline that is fit to the residual. These baseline signals can often be 
attributed to known physical contaminants such as plastic in the receiver coil, or macromolecules. 
Macromolecule signals are created by long chain organic molecules in the tissue and give a gently curved signal 
rather than the sharp peaks of the small metabolites of interest. The signals from macromolecules can be greatly 
reduced by selecting a relatively long echo time. 
 
Line broadening 
Due to several factors, including prevailing noise, the MRS spectrum may feature lines that are not perfectly 
smooth. Since this can influence the quantification outputs, spectra are often ‘smoothed’ using line broadening. 
This can be done either in the frequency domain by convolution of the acquired signal with a  Gaussian or 
Lorentzian function or in the time domain by multiplication of the FID by a Gaussian or Exponential envelope.  
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Quantification  
Metabolite quantification has historically been performed by measuring either the height of a peak, the height 
of a line fitted to the peak, or by measuring the area under the peak curve using numerical integration.  While 
these methods provide some success, more sophisticated quantification techniques are now common. The most 
popular of these is linear combination modelling, which considers an MR spectrum as a mathematical 
combination of the individual spectra of the distinct metabolites and chemicals in the solution/voxel. The set of 
individual spectra is referred to as the basis set. Appropriate basis sets can be simulated for the particular pulse 
sequence conditions.  
 
Phase-cycling 
Phase-cycling is performed both in the simulation and the actual play out of the sequence on the scanner to 
remove unwanted coherences. Phase cycling involves alternating in successive measurements between one of 
four axes when applying the editing or refocussing pulses. 
  
Absolute quantification 
Absolute quantification uses either an internal or an external concentration reference. The metabolite 




) [𝑟]𝐶𝑛𝐶𝑎𝑣𝐶𝑔𝑎𝑖𝑛 , 
where Sm is the signal strength of the metabolite, Sr is the signal strength of the reference, [r] is the concentration 
of the reference in mmols/kgww, Cn is the correction for the number of nuclei in the metabolite signal compared 
to the reference, Cav is the correction for the number of measurements, and Cgain is the correction for the receiver 
gain setting. Since the concentration of pure water (55.5 mols/kgww) and the typical water content of different 
brain tissues are known, it is often used as a reference. The water fraction in grey matter is assumed to be 0.82, 
in white matter 0.73, and in CSF 0.98 (de Graaf 2007).  
 
Examples of Post-processing Software 
LCModel  
LCModel, released by Stephen Provencher in 2001 (Provencher 2018), was the first processing tool to model the 
signal as a linear combination of metabolite spectra. The latest release, version 6.3, provides support for 
modelling MEGA-PRESS data, and while still primarily designed for brain MRS, includes features for muscle, lipid, 
and some other tissues. Since LCModel is not open source and is limited by the basis sets provided, it cannot 
easily be used for custom sequences and pulse shapes. Analyses are performed in the frequency domain, but 
time-domain data can be processed after first being Fourier Transformed.   
 
JMRUI 
Also in 2001, Naressi released a Java-based MRS analysis tool called jMRUI (Java Magnetic Resonance User 
Interface) (Naressi et al. 2001). Although initially free to use, it is now licensed. Like LCModel it incorporates 
prior knowledge, with the main difference being that data are quantified in the time domain rather than the 
frequency domain. jMRUI can process both free induction decays (FIDs) and echoes, and 1D or 2D data, allowing 
it (unlike LCModel) to be used for quantification of 2D NMR data. It features both interactive and non-interactive 
time domain algorithms that are based on non-linear least squares (NLLS) fitting, such as AMARES (Advanced 
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Method for Accurate, Robust, and Efficient Spectral fitting) (Vanhamme et al. 1997) and VARPRO (VARiable 
PROjection) (van der Veen et al. 1988).  
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3 Literature Review  
 
This literature review will look at GABA and glutathione detection, post processing, and some select previous 
studies reporting values which will be useful for comparison with this research. 
 
3.1 Acquisition techniques 
 
A range of detection techniques have been developed for low concentration metabolites like GABA and GSH. 
The following paragraphs will discuss a few of these as they relate to each other.  
In a review paper in 2017 Harris states that for GABA detection, although both MEGA-PRESS and double-
quantum filter experiments have produced robust and repeatable measurements, MEGA-PRESS receives most 
of the attention. For glutathione detection, MEGA-PRESS, polarization transfer, and double quantum filtering 
methods have been developed. While polarisation techniques have not yet been applied to in vivo 
measurements of glutathione, double-quantum filter experiments have also successfully edited the 4.56 ppm 
cysteine moiety (Harris et al. 2017).  
Two other widely implemented editing methods use the BASING (Star-Lack et al. 1997) and double-BASING (Star-
Lack et al. 1998) sequences. These sequences were originally developed to dephase and remove unwanted 
water and lipid signals using a frequency selective inversion pulse, surrounded by crushing gradients on either 
side. It was then modified to additionally selectively invert the lactate doublet at 1.3 ppm and the choline singlet 
at 3.2 ppm. While single BASING does not apply pulses in an interleaved/alternating fashion, but instead simply 
selectively refocuses a coupled signal thereby improving its visibility (Harris et al. 2017), double-BASING does 
employ an alternating pulse scheme making it a J-difference editing technique. The pulse sequence is similar to 
MEGA-PRESS and only differs in the placement of the gradients. In fact the terms double-BASING and MEGA-
PRESS are often used interchangeably (Harris et al. 2017), and in reality scanner vendors develop editing 
sequences with slightly different timing details to either.  
Three methods have been employed to accelerate editing. The first and simplest happens as a consequence of 
a standard MEGA-PRESS experiment, namely co-editing. Co-editing occurs when another spin system, other than 
the spin system of interest, is coupled to the same editing target spin. This spin system will therefore also be 
edited, resulting in another signal in the difference (DIFF) spectrum that does not overlap with the coupled signal 
of interest. For example, when targeting the 1.9 ppm GABA peak, glutamine and glutamate are co-edited, giving 
rise to the Glx coupled signal at 3.75 ppm. This signal is evident in any GABA MEGA-PRESS DIFF spectrum and is 
therefore also commonly quantified.  
The second method expands upon MEGA-PRESS by simultaneously editing two non-overlapping coupled spins. 
Since these spins are part of two different spin systems, editing pulses simultaneously applied at the two 
different target frequencies will result in both spins being edited (Terpstra et al. 2006). This method cannot be 
applied to GABA and GSH detection as their coupled signals are strongly overlapping at 3 ppm.  
The third method resolves the edited signals from two overlapping coupled spins by editing two different target 
spins and using Hadamard encoding. HERMES and HERCULES are both examples of this. Harris et al. (2017) 




Figure 3-1 - Three types of editing acceleration shown, namely: Type 1 - co-editing, Type 2 - dual editing, and Type 3 – encoded 
editing. Blue ends show the frequency location of the editing target spin, and red ends show the frequency location of the 
detected spin. Reproduced from (Harris et al. (2017). 
 
GABA can also be detected using 2D 1H NMR spectroscopy. 2D spectroscopy separates overlapping signals by 
detecting and encoding a second frequency dimension that contains information based on the coupling of 
various resonances, in addition to the usual chemical shift information. This has been demonstrated with spatial 
localisation in phantoms and in vivo for a number of previously developed 2D NMR sequences, including 2D J-
resolved MR spectroscopy (2D J-PRESS), 2D zero-quantum, 2D double quantum, Correlation Spectroscopy 
(COSY), and Spin-echo Correlation Spectroscopy (SECSY) (Ryner et al. 1995a). Measurements with 2D J-PRESS in 
phantoms containing NAA, alanine, choline, myo-inositol, glutamate, glutamine, GABA, taurine, glucose, and 
aspartate (Ryner et al. 1995b), and in vivo, have demonstrated strong coupling in many metabolites. There have 
also been Hadamard encoded variants of the 2D approach called COSY and Total Correlation Spectroscopy 
(TOCSY) (Kupce & Freeman 2003b), and a multi-dimensional approach  builds on these (Kupce & Freeman 
2003a). 
There have been some developments on these techniques recently, such as the development of Localised 
Diagonal Suppressed Spin-echo Correlation Spectroscopy (LDISSECT) (Banerjee & Chandrakumar 2014) by 
adding a 90 degree pulse to a standard SECSY experiment. Or the ‘selective pure shift TOCSY’ (Poggetto et al. 
2016) method, which is designed to help in the identification of the components of complex mixtures such as 
peppermint oil. However, no recent studies could be found which assess the reproducibility of GABA or GSH 
measurements using these methods, or that directly compare one of these 2D NMR methods to edited 1D 
spectroscopy. J-Difference editing is still the most widely used method for GABA and GSH detection (de Graaf 
2007; Harris et al. 2017). 
Despite the widespread use of MEGA-PRESS, another consideration is the differences in acquisition methods 
between MRI vendors; since vendor-native MEGA-PRESS sequences differ in terms of RF pulse shapes, timing, 
durations, and amplitudes, it is difficult to compare quantification between vendors. As such, Saleh and 
colleagues (Saleh et al. 2019) recently developed a standardised MEGA-PRESS sequence with HERMES 
functionality for scanners from each of the four major MRI vendors (Siemens, Philips, GE, and Canon). The 
universal sequence was validated primarily with GABA and lactate phantom data, and some in vivo data. The 
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universal sequence showed increased intraclass correlation (ICC) between data obtained from scanners of 
different vendors compared to the vendor-native sequences, increasing from 0.91 to 0.96 for GABA, and 0.74 to 
0.98 for lactate. This is a promising first step towards sequence standardisation and application of MEGA-PRESS 
towards future clinical applications.  
 
3.2 Post-processing of MRS data 
 
Quantification packages  
The previous chapter introduced the two leading commercial MRS quantification software packages; LCModel 
and JMRUI. Another commonly used quantification package is GANNET which was first published in 2014, and 
was designed specifically for J-difference edited MRS data (Edden et al. 2014). GANNET is written in MATLAB 
and is still free to use. It does not have a user interface but provides automated outputs and plots. GANNET 
quantifies data in the frequency domain. It can process data from all four of the major MRI vendors and performs 
recombination of averages from raw data. GANNET performs automated frequency and phase correction and 
can quantify relative to water reference data.  
All three packages can process MEGA-PRESS data, but only GANNET can process HERMES data. Other sequences 
with complex editing schemes have typically been processed by custom scripts. GANNET quantifies signals by 
fitting a spline to the edited signal of interest in either MEGA-PRESS or HERMES data, but therefore only 




The most commonly used basis set simulation library is FID-A; an open source simulation toolkit, designed to 
generate and process basis sets for linear combination modelling of MRS data (Simpson et al. 2017). The toolkit 
is split into four sets of functions, namely; inputOutput, processingTools, rfPulseTools, and simulationTools.  
The simulation toolbox calculates expected spectra for metabolite spin systems by calculating successive 
evolutions of the density matrix. The simulation toolkit contains a set of metabolite spin system definitions based 
on published values. This includes the J-coupling constants of each proton to every other proton, and the 
frequency shits of the protons. The expected signal of a sequence can then be calculated by combining excitation 
(sim_excite.m), delays (sim_evolve.m), rotation (sim_rotate.m) for ideal rotations, and rotations with a given RF 
pulse (sim_shapedRF.m). These can all be represented by a Hamiltonian transformation; 
𝜎(𝑡) =  𝑒−ℋ𝑡 . 𝜎(0). 𝑒ℋ𝑡 
Where 𝜎 is the density matrix, ℋ is a Hamilton operator, and t is the time. There are also a range of processing 
tools which are useful in handling the spectra and combining them as required. For example op_ampScale.m is 
used to scale a spectra by some factor. 
 
3.3 Previous GABA studies 
 
There has been extensive work relating to brain GABA levels. The following paragraphs present a selection of 
studies which relate to the goals of this research, such as with respect to reproducibility of GABA 
quantification, hardware and software consideration for improved quantification results, etc.  
Much work has been done in assessing the reproducibility of GABA measurements using edited spectroscopy, 
with one recent study examining improvements related to coil channel numbers, macromolecular 
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contamination, and test retest reliability (Shungu et al. 2016). Among other things, the authors documented 
improved sensitivity using head coils with more channels and reported for an 8-channel coil a coefficient of 
variation of 1.25% for GABA+ relative to unsuppressed water in a cohort of seven adults (ages 25.9 ± 2.7 years; 
four women). The authors compared their own results to findings from several other studies that also used 
MEGA-PRESS, and in some instances STEAM, to measure GABA. This table has been reproduced here (Table 
3-1). Notably, the coefficients of variation reported by Shungu et al. using the 8-channel coil are lower than 
values reported by other studies.  
MEGA-PRESS GABA detection has also recently been applied in a large multi-site, multi-vendor, study where 
272 healthy adults were scanned using the vendor native MEGA-PRESS sequences for Siemens, Philips, and GE 
scanners (Mikkelsen et al. 2017). Processing using GANNET yielded a coefficient of variation of 12% for GABA+ 
relative to creatine across the entire cohort. A multilevel analysis of the quantification outcomes 
demonstrated that most of the variability was from differences between participants within each site (72%), 
while site-level differences accounted for 20% of the variation, and vendor-level differences only accounted for 
8% of the variability. 
A follow-up paper that quantified the signals relative to unedited water, accounting for tissue-dependent signal 
relaxation and water visibility effects (Mikkelsen et al. 2018), yielded a coefficient of variation of 17% for GABA+. 
Multilevel analysis showed that subject-level differences now accounted for only 36% of the variability, vendor-
level differences accounted for 53%, and site-level differences 11%. It is interesting to note that when 
unsuppressed water was used as the reference, more variability was attributable to vendor differences. The 
author noted Siemens differences in particular and recommended further standardisation of water reference 
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Recently, Prescot et al. (2018) directly compared GABA quantification using 1D edited spectroscopy and 2D 
spectroscopy (Prescot et al. 2018) in six healthy adult male subjects (mean age ± standard deviation [SD] = 34.2 
± 16.8 years) enrolled in a double-blind, randomized, placebo-controlled study. The study involved the 
administration of a GABA-amino transferase inhibitor to increase brain GABA concentrations. The study, which 
was performed on a Siemens 3T Verio scanner, used MEGA-PRESS for the 1D edited spectroscopy and a 2D J-
resolved sequence for the 2D data. While GABA levels measured using both methods showed similar changes 
over time, the coefficient of variation (CV) of creatine levels (relative to water) was greater for data from 2D J-
PRESS than MEGA-PRESS (Table 3-2). 
 
Table 3-2 - Mean within-subject CV (%c ± SD) of creatine (Cr; normalised to CSF-corrected unsuppressed water) for both 
measurement techniques and the two treatment cohorts. The final column shows the effect size for drug-induced changes 
in GABA levels (normalised to creatine).cc (Prescot et al. 2018). 
GABA concentration for variation for MEGA-PRESS and 2D J-Resolved NMR  
- reproduced from Prescot et al. (2018) 
Cohort  Technique CV (Cr:water) 
ΔGABA Effect Size 
(day7, day 13) 
CPP-115 
MEGA-PRESS 4 ± 1 7.2, 2.1 
2D J-Resolved  7 ± 2 4.3, 2.0 
Placebo 
MEGA-PRESS 5 ± 2 N/A 
2D J-Resolved  9 ± 4 N/A 
 
 
3.4 Previous GSH studies 
 
Glutathione is most commonly detected with MEGA-PRESS by editing the 4.56 ppm peak on the cysteine moiety. 
However, this co-edits the NAA-aspartyl peaks, effects that can be minimized by setting the echo time to 68 ms 
(Terpstra et al. 2003). 
Not all recent studies report improvements using editing techniques. A recent study assessing the reproducibility 
of glutathione measurements in 10 subjects who were repeat scanned using PRESS, SPECIAL, Phase-rotation 
STEAM (PR-STEAM), and MEGA-PRESS (Wijtenburg et al. 2019), found that PR-STEAM had the lowest mean 
coefficient of variation (CV) and absolute difference (AD) (5.4 and 7.5%, respectively), followed by PRESS (5.8 
and 8.2%, respectively) and SPECIAL (8.0 and 10.1%, respectively). MEGA-PRESS performed the worst (13.5 and 





This project comprised three major components: (i) porting the HERMES sequence previously implemented by 
researchers from Johns Hopkins on Philips (Chan et al. 2016) to a Siemens platform (section 4.1), (ii) developing 
code for signal processing and metabolite quantification of data acquired using this sequence (section 4.2), and 
(iii) testing and validation of the sequence and metabolite quantification algorithms both in phantoms and in 
vivo (section 4.3). 
This project presents a collaboration between the Universities of Cape Town and Prof Edden’s group at Johns 
Hopkins University in Baltimore, USA, where the HERMES sequence was first implemented. Data for this project 
were acquired according to protocols that had been approved by the Faculty of Health Sciences Human Research 
Ethics Committee of the University of Cape Town and the Institutional Review Board of Johns Hopkins. All 
participants provided written informed consent. 
 
4.1 HERMES Sequence Development  
 
Siemens, Philips, and GE have commercially available PRESS sequences. The commercial name for the Siemens 
PRESS sequence is svs_se, and for their MEGA-PRESS WIP is svs_edit. Since the latter sequence edits only for a 
single metabolite, the svs_edit.h and svs_edit.cpp source code files were modified to implement HERMES. 
Sections below describe changes that were made to the sequence user interface, the RF pulse shapes, and 
sequence timing. 
 
4.1.1 Sequence User Interface 
 
The principal difference between MEGA-PRESS and HERMES is that instead of two sub-experiments with editing 
pulses ON or OFF, respectively, there are four sub-experiments  one with dual editing pulses (i.e. editing for 
both metabolites), two with single lobe editing pulses (one for each of the metabolites separately), and one with 
no editing pulses. 
In MEGA-PRESS, the ON and OFF sub-experiments are interleaved. For HERMES it is necessary to interleave 
four different sub-experiments by applying different combinations of two distinct editing pulses. A checkbox 
(HERM_GABA_GSH) was therefore added in the svs_edit WIP special card that would, when selected, allow a 
second editing frequency to be specified (Figure 4-1). This implementation allows the user to run MEGA-PRESS 
and HERMES using the same sequence. The sequence essentially performs interleaved acquisitions for all 
possible permutations of the editing pulses (2 permutations in the case of MEGA-PRESS, and 4 for HERMES) 
without requiring any adjustments to sequence timing or pulse shapes. This is achieved by switching in the 
sequence between a two-step (MEGA-PRESS) and four-step (HERMES) editing loop (‘m_editloop’). 
In our implementation, the ‘Edit Pulse Frequency 1’ and ‘Edit Off Frequency’ boxes always remain active and 
are set for GABA editing. Their default values are 1.9 ppm (i.e. editing for the GABA-H3 quintet) and 7.5 ppm, 
respectively. The latter ensures that the editing pulse in the OFF sub-experiment is placed far from the useful 
portion of the spectrum where no coupled spin systems interfere with the spin systems of interest. Therefore, 
the first sub-experiment (A) is performed with the first editing frequency (GABA) ON and the second sub-
experiment (B) with the first editing frequency OFF. This is the standard MEGA-PRESS acquisition. 
Only when the HERM_GABA_GSH checkbox is selected, does the ‘Edit Pulse Frequency 2’ box become active. 
The default value of 4.56 ppm allows editing of the GSH cysteine moiety doublet-of-doublets. Sub-experiment 
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C therefore edits for GSH (GSH ON), and sub-experiment D for both GABA and GSH (i.e. GABA ON and GSH 












Table 4-1: Order of acquisition of the different edited spectra in our HERMES implementation. 
Experiment Editing Pulses 
GABA GSH 
A ON OFF 
B OFF OFF 
C OFF ON 
D ON ON 
 
 
All other sequence cards and settings remained unchanged.  
 
Editing pulse parameters are set using Siemens closed-source functions setTypeRefocussing, setDuration, 
setFlipAngle, setInitialPhase, setFamilyName, setThickness, setFrequency, and setPhase. 
 
 
Figure 4-1 - HERMES sequence special card as it appears in the scanner user interface, featuring HERMES checkbox and 




4.1.2 RF pulse design 
 
Sequence standardisation is an important research focus in MRS as it allows for comparison of data between 
vendors. Part of this project was to standardise the RF pulse shape and sequence timing of the Siemens HERMES 
implementation to that used in the previous Philips implementation. 
Edited MRS pulse sequences feature 3 types of RF pulses: excitation, refocusing, and editing pulses. In the 
following sections the pulses used by the Siemens MEGA-PRESS WIP are compared to those selected for the 
HERMES sequence.  
  
Siemens MEGA-PRESS WIP - ‘svs_edit’ 
 
 
Figure 4-2 - Siemens svs_edit excitation pulse (‘hsinc_400_8750’) 
 
For excitation, the Siemens MEGA-PRESS WIP (svs_edit) uses a symmetrical hsinc_400_8750 pulse (Figure 4-2) 
from the hsinc_400_8750 family with 400 samples, integral of the normalised amplitude (AMPINT) 45.490761, 
integral of the absolute magnitude of the normalised pulse (ABSINT) 66.644113, integral of the calculated power 
(POWERINT) 41.497912, and logical reference gradient (amplitude of a slice selection gradient required to excite 




Figure 4-3 - Siemens svs_edit refocussing pulse (‘mao_400_4’). Note that the Siemens pulse tool, which generated the points 
in the figure, uses Fourier Transform techniques to create the frequency domain profile. Fourier Transform methods are 
inaccurate for inversion and refocussing pulses, and as such only the time domain profile is shown for this pulse.  
 
The refocussing pulse is a symmetrical 180 degree mao_400_4 pulse (Figure 4-3) from the mao_400_4 family 
with parameters: 
Samples :   400 
AMPINT:   36.711385 
ABSINT:    68.374723 
POWERINT:  37.032906 
REFGRAD:   2.752000 
 
By contrast, the editing pulses are built within the sequence code rather than importing external pulse shapes.  
 
HERMES  
Two major changes required for the HERMES implementation were: 
1. Importing the editing pulses from externally generated .rda files rather than manually building them in 
the sequence code. This makes it easier to update and change the pulses, facilitating standardisation.  
2. Replacing all the pulses with ‘universal’ pulses that closely match those used in the Philips 
implementation of HERMES. The pulses used were designed and shared by Prof Richard Edden from 
Johns Hopkins University. Matching the pulse shapes across platforms reduces the potential impact of 
pulse shape variations on cross vendor comparisons.   
 
Figure 4-4  – HERMES excitation pulse (‘spreddenrex’). Note that the Siemens pulse tool, which generated the points in the 
figure, uses Fourier Transform techniques to create the frequency domain profile. Fourier Transform methods are inaccurate 
for inversion and refocussing pulses, and as such only the time domain profile is shown for this pulse. 
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For excitation, an asymmetrical spreddenrex (Figure 4-4) pulse was used with 200 samples, AMPINT 10.023573, 
ABSINT 23.982528, POWERINT 11.571791, and REFGRAD 7.421000. Refocussing used the eddenrefo (Figure 4-5) 




Figure 4-5 – HERMES refocussing pulse (‘eddenrefo’). Note that the Siemens pulse tool, which generated the points in the 
figure, uses Fourier Transform techniques to create the frequency domain profile. Fourier Transform methods are inaccurate 
for inversion and refocussing pulses, and as such only the time domain profile is shown for this pulse. 
 
Single and dual lobe editing used the sl_edden_edit (Figure 4-6) and DUALBAND2 (Figure 4-7) pulses, 
respectively, both with 200 samples and REFGRAD 1. For the former, AMPINT was 110.291802, ABSINT 110. 
291802, and POWERINT 82.725094, while parameter values for the latter were AMPINT 55.602906, ABSINT 













4.1.3 Sequence timing 
Adapting the svs_edit WIP for HERMES involved changing the timings of the editing pulses, the RF excitation, 
and the first echo. 
 
Editing pulses 
Maximum editing efficiency requires that the time between the two editing pulses equals half the total echo 
time, i.e. 
𝑇𝐸𝑑𝑖𝑡 2 − 𝑇𝐸𝑑𝑖𝑡 1 =
𝑇𝐸
2
 ,   (Philips and universal implementation timing),  
while maximum echo signal amplitude requires that the editing pulses be placed symmetrically around the 
second refocussing pulse (Figure 4-8), i.e.  
|𝑇𝐸𝑑𝑖𝑡1 − 𝑇𝑅𝑒𝑓𝑜𝑐𝑢𝑠2| =  |𝑇𝐸𝑑𝑖𝑡2 − 𝑇𝑅𝑒𝑓𝑜𝑐𝑢𝑠2|.  (Siemens WIP timing) 
In the latter, the spoiler gradients on the x-axis are also typically placed symmetrically about the second 
refocussing pulse. Due to the editing pulses being long (17.9 ms in the Siemens WIP and 20 ms in the Philips and 
universal implementations), both the above conditions cannot be met simultaneously, so that sequences 
typically maximise either editing efficiency (the difference between sub spectra) or echo amplitude. The HERMES 
implementations by Saleh et al. (2016) on the Philips platform optimised editing efficiency, while the Siemens 
svs_edit WIP optimises the echo amplitude (Figure 4-8).  
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Figure 4-8 – Timing of the Siemens MEGA-PRESS WIP ('svs_edit')  
 
Figure 4-9 shows the HERMES pulse sequence that was adapted from the svs_edit pulse sequence. In addition 
to replacing the pulses with universal pulses as discussed previously, two new time periods were defined – the 
interval ‘m_postEdit1’ between the first editing pulse and the second refocussing pulse, and the time 
‘m_preEdit2’ between the second refocussing pulse and the second editing pulse. These values were chosen 
such that the difference between the editing pulses would be half the total echo time, while ensuring that the 
first editing pulse is positioned halfway between the excitation pulse and the second refocussing pulse, i.e. 
𝑇𝐸𝑑𝑖𝑡1 = 𝑇𝐸𝑥𝑐 + 
𝑇𝑅𝑒𝑓𝑜𝑐𝑢𝑠𝑠𝑖𝑛𝑔2−𝑇𝐸𝑥𝑐
2
   (HERMES timing condition) 
TEdit1 is the time when the first editing pulse is applied, TExc the time when the excitation pulse is applied, and 
TRefocussing2 the time of the second refocussing pulse. 
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Figure 4-9  – Timing of the HERMES pulse sequence 
 
Excitation pulse  
Notably, the use of an asymmetric excitation pulse also affects the sequence timing. Since most of the energy is 
imparted under the tallest peak, this is the time when excitation is assumed to have occurred in timing 
calculations. For symmetric pulses, such as the one shown on the right in Figure 4-10, this occurs at the mid-
point (0.5) of the pulse duration. In contrast, this happens later for an asymmetric pulse, as shown on the left in 
Figure 4-10. The  asymmetry was set in the sequence code and any subsequent timing references in the original 






Figure 4-10 - Diagram of the spreddenrex (HERMES sequence) and hsinc_400_8750 (svs_edit sequence) excitation pulses and 
their asymmetry factors 
 
TE1 
The final notable timing change for HERMES compared to the svs_edit WIP was hard coding the time TE1 to 13.1 
ms, regardless of the total TE selected. This fixes the timing of the first refocussing pulse. In the original svs_edit 
WIP, TE1 depended on the pulse duration of the excitation pulse. 
 
4.1.4 Other sequence development details 
 
Simulation and POET 
The POET tool in IDEA allows the sequence user interface to be visualised (such as the image in Figure 4-1). 
Simulation is also possible either from POET directly or using the ‘sim’ command. Figure 4-8 and Figure 4-9 in 
the previous section were generated using the ‘sim’ command. 
 
Unit tests  
A useful first check of the newly developed sequence is the Unit Test, which is typically performed before 
installing the sequence on the scanner. The Unit Test performs a comprehensive test on a number of sequence 
details. Figure 4-11 shows a sample result from a Unit Test performed on a version of the svs_edit sequence. 
 
Figure 4-11 - Sample Unit Test results (incomplete) from svs_edit 
40 
 
Compiling binaries and installation 
The sequence source code was compiled using IDEA. This can be done in one of three modes: debug, release, 
and SO (where ‘SO’ is a reference to the Linux binary file type .so, meaning ‘shared object’). The debug 
compilation can be used to perform various checks from the IDEA command shell. However, the scanner 
ultimately needs the ‘release’ binaries (which run on the Windows host - .dll) and the ‘SO’ binaries (which run 
on the Linux based Measurement and Reconstruction System (MARS) - .so).  
The sequence binaries as well as the ICE reconstruction binaries were installed on the scanner. Notably the ICE 
reconstruction files were not adjusted for this project. Therefore, Hadamard recombination of sub-experiments, 
and visualising of difference spectra, could not be done directly on the scanner. Raw data were therefore 
exported from the scanner using the Twix program and processed offline as described in the next section.  
 
4.2 Development of a Simultaneous Modelling Processing Tool  
 
For this research a quantification technique was developed that simultaneously fits simulated basis sets (‘prior 
knowledge’) for all the acquired spectra rather than just the relevant difference spectra. The basis sets were 
simulated using the FID-A toolkit. In addition, phase cycling was applied to the simulations. The following 
sections present more details on the modelling technique. 
 
4.2.1 Generating a HERMES Basis set 
 
A HERMES basis set comprising 16 metabolites was generated by simulating with FID-A, at the centre of a 3x3x3 
cm3 voxel, a spectrum for each metabolite for each of the four sub-experiments (A – GABA ON; B – BOTH OFF; 
C – GSH ON, D – BOTH ON). The metabolites included in the basis set were ascorbic acid (Asc), aspartate (Asp), 
creatine (Cr), γ-aminobutyric acid (GABA), glycero-phosphocholine (GPC), glutathione (GSH), glutamine (Gln), 
glutamate (Glu), myo-inositol (Ins), lactate (Lac), N-acetyl aspartyl glutamate (NAAG), N-acetyl aspartate (NAA), 
phosphocholine (PCh), phosphocreatine (PCr), scyllo-inositol (Scyllo), and water (H2O). While the spectra 
generated for sub-experiments A and B (or B and C) can be used to generate a basis set for GABA (or GSH) edited 
MEGA-PRESS, the unedited sub-experiement (B) cannot be used as a basis set for PRESS due to the fact that the 
timing and pulses used in the universal HERMES sequence are not the same as those used in the Siemens PRESS 
sequence (‘svs_se’) and would lead to inaccurate results.  
In all simulations, excitation was assumed to be a perfectly uniform non-frequency selective pulse, while actual 
sequence timing and RF profiles were used for signal evolution and RF refocussing, respectively. For each basis 
set simulation, 2048 points were calculated and linewidths were set to 3 Hz. Effects of frequency drift, phase 
drift and noise were ignored.  
Complete phase cycling, where every pulse can have one of four possible phases (i.e. 0, 90, 180 or 270 degrees), 
requires that each basis set simulation be repeated for all possible combinations of the pulses’ phases. The 
number of unique phase cycling combinations are given by 
𝑁𝑜. 𝑜𝑓 𝑝ℎ𝑎𝑠𝑒 𝑐𝑦𝑐𝑙𝑖𝑛𝑔 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛𝑠 =  𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝ℎ𝑎𝑠𝑒𝑠𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑢𝑙𝑠𝑒𝑠   ,  
with the Number of phases equal to four. 
However, if the number of possible phases for the different pulses differ, the number of possible phase cycling 
combinations for k pulses are given by 
𝑁𝑜. 𝑜𝑓 𝑝ℎ𝑎𝑠𝑒 𝑐𝑦𝑐𝑙𝑖𝑛𝑔 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛𝑠 =  𝑃𝑢𝑙𝑠𝑒1𝑃ℎ𝑎𝑠𝑒𝑠  ×  𝑃𝑢𝑙𝑠𝑒2𝑃ℎ𝑎𝑠𝑒𝑠  × … × 𝑃𝑢𝑙𝑠𝑒𝑘𝑝ℎ𝑎𝑠𝑒𝑠  , 
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where PulseiPhases is the number of phases to be cycled through for pulse i, and  i = 1 to k. 
In addition to repeating each metabolite’s simulation for each sub-experiment and all possible phase cycling 
combinations, the basis set simulation may also need to be repeated for multiple points on the voxel (if desired) 
to account for within-voxel spatial variation of the metabolite signal (as explained further below).  
As such, the total number of simulations (N) required to generate a complete basis set is given by 
𝑁 = 𝑁𝑜. 𝑜𝑓 𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒𝑠 × 𝑁𝑜. 𝑜𝑓 𝑠𝑢𝑏 − 𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑠 (4 𝑓𝑜𝑟 𝐻𝐸𝑅𝑀𝐸𝑆) ×
𝑁𝑜. 𝑜𝑓 𝑝ℎ𝑎𝑠𝑒 𝑐𝑦𝑐𝑙𝑖𝑛𝑔 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛𝑠 × 𝑁𝑜. 𝑜𝑓 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛𝑠 𝑖𝑛 𝑣𝑜𝑥𝑒𝑙. 
As a general rule of thumb within-voxel spatial variation of the metabolite signal arises when the bandwidth of 
the slice selective pulses are close to the chemical shift difference of the coupled spin-systems (Edden & Barker 
2007). In our implementation, the FWHM bandwidth of the refocussing pulse is 1228 Hz and the chemical shift 
difference for GABA is 144 Hz ((3.012 - 1.889 ppm) × 128 MHz) and for GSH is 209 Hz ((4.561 - 2.926 ppm) × 128 
MHz) (Govindaraju et al. 2000). Since FID-A can account for spatial variation, initial simulations were done with 
3 spatial distances in each direction of the 3x3x3 cm3 voxel i.e. x=(-1.5, 0, 1.5)cm, y=(-1.5, 0, 1.5)cm, and z=(-1.5, 
0, 1.5)cm – giving 27 points. However, due to the refocussing bandwidth being nearly an order of magnitude 
larger than the chemical shift difference for GABA and nearly 6 times larger for GSH, and because of the already 
intensive computational requirements of the simulation, the simulations were performed only at the centre of 
the voxel for the final basis set i.e. number of positions in voxel = 1. 
For HERMES, which comprises 2 refocussing (RP) and 2 editing (EP) pulses, complete phase cycling would involve 
256 phase cycling combinations (i.e. 4 phases for each of the 4 pulses). In an effort to reduce the computational 
burden, the effect that reducing the number of phase cycling steps would have on the spectral lineshapes was 
examined. This optimisation was performed on a simple singlet before being applied during the final basis set 
simulation. Figure 4-12 shows sum and difference spectra for a singlet simulated using complete phase cycling 
(i.e. combining results from 256 simulations), while Figure 4-13 shows the phase distortion present in the GABA 
difference spectrum for two-step (0, 90 degree) phase cycling (i.e. 24 = 16 simulations). Complete phase cycling 
of one pulse and two-step phase cycling for the other three pulses results in significant distortion of both 
difference spectra, as shown in Figure 4-14 for different phase cycling combinations. In contrast, two-step phase 
cycling of the editing pulses and complete phase cycling of the refocussing pulses yields difference spectra 
(Figure 4-15) with lineshapes indistinguishable from those generated using complete phase cycling (Figure 4-
12), while achieving four-fold acceleration (64 phase cycles compared to 256). This strategy was therefore 
employed when simulating the metabolite spectra for the different sub-experiments to reduce the computation 
time. In total,    
𝑁 = 16 (𝑀𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒𝑠) × 4 (𝑆𝑢𝑏 − 𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑠) × 64 (𝑝ℎ𝑎𝑠𝑒 𝑐𝑦𝑐𝑙𝑖𝑛𝑔𝑠) × 1(𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛) = 4096  






Figure 4-12 - Singlet density matrix simulation for HERMES sequence, showing GABA and  GSH weighted difference spectra 
(A-B-C+D and -A-B+C+D, respectively) and SUM spectrum, for 4-step phase cycling on all refocussing and editing pulses. 
 
 
Figure 4-13 - Singlet density matrix simulation for HERMES sequence, showing GABA and  GSH weighted difference spectra 
(A-B-C+D and -A-B+C+D, respectively) and SUM spectrum, for 2-step phase cycling on all refocussing and editing pulses. EP1 





Figure 4-14 - Singlet density matrix simulation for HERMES sequence showing GABA and  GSH weighted difference spectra 
(A-B-C+D and -A-B+C+D, respectively) and SUM spectrum, for three 2-step and one 4-step phase cycles as shown on each 






Figure 4-15 - Singlet density matrix simulation for HERMES sequence showing GABA and  GSH weighted difference spectra (A-B-
C+D and -A-B+C+D, respectively) and SUM spectrum, for two 4-step and two 2-step phase cycles as shown on each figure. EP1 
and EP2 are the two editing pulses; RP1 and RP2 are the two refocussing pulses. 
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Figure 4-16 shows the spectra generated for GABA for each of the HERMES sub-experiments. Note how the two 
outer peaks of the triplet at 3 ppm are correctly inverted relative to the centre peak when no GABA editing pulse 
is applied (i.e. sub-experiments B and C), while they are not inverted when a GABA editing pulse is applied (i.e. 





















Figure 4-16 - GABA spectra simulated using FID-A for each HERMES sub-experiment. 
 
For all 16 metabolites, spectra simulated for sub-experiment B (GABA OFF, GSH OFF) were compared to 
lineshapes from literature. A complete HERMES basis set was finally generated by appropriately combining the 
spectra simulated for the different sub-experiments (sum (A+B+C+D), zero (-A+B-C+D), GSH (-A-B+C+D) and 
GABA (A-B-C+D)) and concatenating the outputs. Figure 4-17 shows the resulting HERMES basis set comprising 




A - GABA ON, GSH OFF 
B - GABA OFF, GSH OFF 
C - GABA OFF, GSH ON 
D - GABA ON, GSH ON 
  4                              3.5                             3                              2.5                            2                               1.5                            1 
Simulated GABA Spectra 
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Figure 4-17 – HERMES basis set comprising sum, zero, GSH and GABA spectra for 16 metabolites in the range 1.5 – 4.5 ppm. 
Spectra simulated for the different sub-experiments were combined according to the Hadamard matrix and the outputs 





Figure 4-18 – MEGA-PRESS basis sets for GABA and GSH comprising sum and difference spectra for 16 metabolites in the 




4.2.2 Simultaneous linear combination modelling 
 
HERMES data were exported from the scanner in raw format (.dat) using the TWIX program and processed using 
tools from GANNET, FID-A, SPM, and in-house MATLAB scripts. The processing  pipeline is shown in Figure 4-19. 
The fitting code was written in MATLAB and comprised modules: initialise settings, prepare data, prepare basis 




Figure 4-19 – Data processing pipeline. 
0. Initialise settings 
Set fit ranges, in vivo/phantoms 
1. Prepare data 
Average frequency domain sub-experiments, 
create Hadamard recombinations, 
concatenate, etc. 
2. Prepare basis sets 
Resize and resample basis sets, create 
Hadamard recombinations, manually correct 
frequency shifts arising from temperature 
differences in phantom data, etc. 
3. Fit 
Set least-squares algorithm settings, 
run/minimize model residual, spline residual, 
iterate fit and spline 
4. Quantify 
Calculate water conc. from segmentation, 
scale water signal, scale metabolite signal 
5. Plot  
Debugging plot functions (pre-fit, post-fit, 
post-spline, metab. weights) 
GannetLoad  
Converts to MATLAB 
data objects, frequency 
and phase correction 
MRS data 
 
6. Save outputs 
Prepare and save output structure, save main 
plot 
FID-A 











Data processing pipeline 
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Some items to note on the modelling approach; 
 The simultaneous linear combination modelling pipeline used GannetLoad to import the raw data, to 
convert the raw scanner data into MATLAB data structures, and to perform frequency and phase 
correction. The GANNET pipeline would usually then proceed with GannetFit, GannetSegment, and 
GannetQuantify to fit and quantify the data. These tools were not used in the simultaneous linear 
combination modelling pipeline.   
 SPM was used to segment the voxel into grey matter, white matter, and CSF. This was done by co-
registering the voxel coordinates from the header information of the MRS data file on the T1 image. 
The T1 image was then cropped to the size of the voxel and tissue fractions computed.  
The simultaneous linear combination modelling approach developed as part of this project differs from existing 
methods in that the Hadamard combinations (i.e. the sum, zero, GSH and GABA spectra) were concatenated 
into a single spectrum prior to fitting. Notably, the basis sets were similarly concatenated. Figure 4-20 shows the 
model parameters. The model comprised 27 parameters – 16 metabolite weightings (P1 - P16), 8 parameters 
(P17 – P24) for baseline correction (two parameter estimates per sub-spectrum), 2 for line broadening (P25, 
P26), and one (P27) to correct small frequency shifts.   
 
 
Figure 4-20 - Graphical illustration of the model used in the least squares fitting algorithm, where P denotes a parameter, 
black lines are data, orange lines are baseline corrections, and blue lines are the basis set 
 
Line broadening involved convolution with Gaussian and Lorentzian functions. The width was set to 1 ppm and 





where a is the peak height, b is the peak centre, and c is the standard deviation.  
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where Γ is the FWHM, and x0 is the peak centre.  
In the model, the centre points of the Gaussian and Lorentzian were both set to zero, while the remaining three 











Γ = 𝑃25 − 𝑃25 × 𝑃26 
 
Since straight lines cannot adequately remove macromolecule contributions from the baselines, splines were 
fitted to the residuals iteratively for additional baseline correction as illustrated in Figure 4-21. It should be noted 
that the splines were fit to the residuals of each recombination separately (SUM, ZERO, GSH, GABA) by reshaping 
the spectra after the first optimisation, splining, and then concatenating again before the next iteration of the 
least squares optimisation. This improves the fit at the edges of the separate spectra which is often where 
significant macromolecule signal is found. 
 
 
Figure 4-21 - Iterative fitting of splines to the residual for improved baseline correction within the Simultaneous linear 
combination modelling pipeline 
 
Figure 4-22 shows an example of how this splining procedure improved the fitting of in vivo data. 
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Figure 4-22 - Sample in vivo data showing the initial model solution (top two spectra) and the spline (red line) fitted to the 
residual, as well as the final iteration of the model and residual (bottom two spectra). The model Root-mean-square 
Deviation (RMSD) is 38% lower after the splining procedure. 
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Least squares algorithm 
Initial weights for the least squares algorithm were chosen from typical in vivo concentrations (Govindaraju et 
al. 2000). These are listed in Table 4-2. The ‘lsqcurvefit’ function in MATLAB 2018a was used for the non-linear 
least-squares regression. The inputs and outputs are summarised in Table 4-3. 
 











for lsqcurvefit Full name  Abbr. 
P1 Ascorbic acid Asc 1.0 (de Graaf) 1 [0 1E8] 
P2 Aspartate Asp 1.0 – 1.4  1 [0 1E8] 
P3 Creatine Cr 5.1 – 10.6 8 [0 1E8] 
P4 Aminobutyric acid GABA 1.3 – 1.9 2 [0 1E8] 
P5 Glycero-
phosphocholine 
GPC 1.0 1 [0 1E8] 
P6 Glutathione GSH 2.0 2 [0 1E8] 
P7 Glutamine Gln 3.0 – 5.8  4 [0 1E8] 
P8 Glutamate Glu 6.0 – 12.5 9 [0 1E8] 
P9 Myo-inositol Ins 3.8 – 8.1 6 [0 1E8] 
P10 Lactate  Lac 0.4 1 [0 1E8] 
P11 N-acetyl aspartyl 
glutamate 
NAAG 0.6 – 2.7  2 [0 1E8] 
P12 N-acetyl aspartate NAA 10.3 10 [0 1E8] 
P13 Phosphocholine PCh 0.6 1 [0 1E8] 
P14 Phosphocreatine PCr 3.2 – 5.5  4 [0 1E8] 
P15 Scyllo-inositol  Scy 0.3 – 0.6  1 [0 1E8] 
P16 Water H2O  10 [0 1E8] 
 Property description   
P17 Y-intercept of SUM baseline 0 [-1 1]E6 
P18 Y-intercept of ZERO baseline 0 [-1 1]E6 
P19 Y-intercept of GSH baseline 0 [-1 1]E6 
P20 Y-intercept of GABA baseline 0 [-1 1]E6 
P21 Gradient of SUM baseline 0 [-1 1]E6 
P22 Gradient of ZERO baseline 0 [-1 1]E6 
P23 Gradient of GSH baseline 0 [-1 1]E6 
P24 Gradient of GABA baseline 0 [-1 1]E6 
P25 Convoluted Lorentzian and Gaussian combined 
parameters 
See formula above 
1 [0.01 1] 
P26 0.5 [0 1] 




Table 4-3 - Non-linear regression analysis function inputs and outputs explained 
MATLAB function 
[x, resnorm, residual, exitflag, output, lambda, jacobian] = lsqcurvefit(fun, x0, xdata, ydata, lb, ub, options) 
Input General description Description for this use-case 
fun Non-linear function fun(x,xdata) MRS model as illustrated in Figure 4-20. 
x0 Initial weights. Initial weights for parameter estimates (Table 4.2). 
xdata Input data for the model. The basis set resampled to the length of the data. 
ydata Response data from the model 
y=fun(x,xdata) 
The concatenated MRS spectrum. 
lb Lower bounds. Zero concentrations, baseline shift, line 
broadening, and frequency shift.  
ub Upper bounds. Metabolite weights two orders above expected, 
etc. 
options Optimisation options.  Max fit iterations = 1e6 
Function tolerance = 1e-8 





The fitting model quantifies metabolite levels in absolute terms by using the water scan as an internal reference 




) [𝑟]𝐶𝑛𝐶𝑎𝑣𝐶𝑔𝑎𝑖𝑛 . 
The parameter estimates P1-P15 are used as the metabolite signal strengths Sm, and the water parameter 
estimate P16 (from the water reference scan) as the reference signal Sr.  
Cn: In the basis set generated, signal amplitudes were already adjusted for the number of nuclei, i.e. in each  
basis spectrum (e.g. GABA) the height of the peaks were scaled according to the number of active nuclei at that 
shift/frequency. These weights come directly from the FID-A ‘sys’ matrices. As such, no further adjustment was 
necessary and Cn=1.  
Cav: The correction for the number of averages was also not necessary as the sub-experiment scans were 
averaged not summed, i.e. the spectra were essentially rescaled to the size of the individual scans prior to fitting 
regardless of the number of averages acquired (16 for water reference and 320 for metabolite scans).  
Cgain: The receiver gain was the same for both the metabolite and water reference scans, so no correction was 
needed.  
[r]: Tissue fractions (GM, WM and CSF) were obtained from segmentation of the voxel on the co-registered T1 
weighted image. The water concentration is then given by  
[𝑟] = 55.5 (𝐺𝑀 × 0.82 + 𝑊𝑀 × 0.73 + 𝐶𝑆𝐹 × 0.98) 
 
Phantom data  
The code also features the option to switch between phantom and in vivo data. While the intention was to 
process the phantom and in vivo data as similarly as possible so as to avoid bias, two changes were required 
when processing phantom data, namely 
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 Enabling a manual frequency shift for phantom data: the code plots the data alongside the metabolite 
basis set (scaled by the initial weights) and allows the user to manually shift the frequency of the basis 
set upon reviewing the plot. The temperature of phantoms is not the same as in vivo tissue, which 
causes a frequency shift. When the phantom is taken from a fridge at 5 degrees Celsius, the frequency 
shift is of the order of 0.2 ppm. Although the model allows the frequency to be shifted by 200 Hz in 
either direction (P27 from Figure 4-20), this is sometimes less than the temperature-related frequency 
shift that has occurred. Since widening the upper and lower bounds for P27 causes unstable fitting, a 
manual frequency shift was rather allowed.  
 Bypassing tissue segmentation: the segmentation section of the code is bypassed for phantom data and 





HERMES sequence and simultaneous linear combination modelling algorithm were tested in both phantoms and 
in vivo. 
 
4.3.1 Phantom testing 
 
Three sets of phantoms were constructed (Table 4-4). Design guidance was obtained from the LCmodel manual 
(Provencher 2018), in particular regarding the inclusion of the pH correcting and preservative compounds 
HK2PO4, H2KPO4, and N3Na, respectively. Quantities of reagents were calculated using the published molar mass 
values, the known container volume, and the desired concentration according to 
𝑚 = [𝑟𝑒𝑎𝑔𝑒𝑛𝑡]𝑀𝑉, 
where m is the mass in grams, [reagent] is the desired reagent concentration in mols/litre, M is the molar mass 
of the reagent in grams/mol, and V is the container volume in litres.  
 
Table 4-4 - Details of phantom sets used in the testing and evaluation of the sequence and fitting routine 








[N3Na] (g/l) Volume (mL) 
1 GABA 25 
GSH 25 
72 28 1 1165 
2 GABA 25 
 
72 28 1 1165 
      










[N3Na] (g/l) Volume (mL) 
1 Cr 20 72 28 1 50 
2 GABA 10 72 28 1 50 
3 GABA 10  
GSH 10 
72 28 1 50 
4 GABA 10  
GSH 20 
72 28 1 50 
5 GABA 20  
GSH 10 
72 28 1 50 
6 GABA 20  
GSH 20 
72 28 1 50 
7 GSH 10 72 28 1 50 
8 NAA 10 72 28 1 50 
      








[N3Na] (g/l) Volume (mL) 









Initial phantom scans during early stages of sequence development were performed at Johns Hopkins University 
on a 3T Siemens Prisma scanner running software version VE11B. Subsequent sequence testing was done at the 
Cape Universities Body Imaging Centre (CUBIC) on a 3T Siemens Skyra running software version VE11C using 
phantom set #1. 
Phantom sets #2 and #3 were used to validate the accuracy of the fitting algorithm and absolute quantification.  
 
4.3.2 In vivo Testing  
 
All scanning was conducted according to protocols that had been approved by the Human Research Ethics 
Committee of the Faculty of Health Sciences at the University of Cape Town.  
  
Table 4-5 - Scanning protocol  















Localizer - - - - - - 2.5 
Calibration and Shimming - - - - - - 4 
MPRAGE - - - - - - 5 
svs_se (PRESS) 2000 80 64 SWS Siemens - 4 
MEGA-PRESS GABA 2000 80 320 SWS Universal 1.9 10 
MEGA-PRESS GABA water  2000 80 16 Only RF off Universal 1.9 2 
MEGA-PRESS GSH 2000 80 320 SWS Universal 4.56 10 
MEGA-PRESS GSH water 2000 80 16 Only RF off Universal 4.56 2 
HERMES 









      Total 51.5 
SWS = strong water suppression, AVGS = averages, RF = radio frequency 
 
24 healthy adult participants (12 male, mean age 26 ± 2 yr) were scanned on the 3T Siemens Skyra MRI with a 
32-channel head coil at the Cape Universities Body Imaging Centre (CUBIC) in Cape Town using the protocol 
detailed in Table 4-5. All participants provided written informed consent. MRS acquisitions were performed in a 
single 3 × 3 × 3 cm3 midline parietal region with 20-ms editing pulses, 2048 data points and 2 kHz spectral width. 
In three participants, the scanning session was repeated three times. Figure 4-23 shows typical voxel placement 
for the midline parietal region. 
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Figure 4-23 - Sample midline parietal voxel placement shown for subject G13. 
 
Data were analysed using our simultaneous linear combination fitting algorithm.  
To compare MEGA-PRESS and HERMES data, without biasing the latter by the improvement inherent to fitting 
to four Hadamard re-combinations rather than two (sum and difference) as in MEGA-PRESS, HERMES data were 
first processed using only two re-combinations, namely the sum spectrum (A+B+C+D) and either the 
combinations for GSH- (-A-B+C+D) or GABA- (A-B-C+D) editing. In this way we could directly compare GABA- (or 
GSH) edited MEGA-PRESS to GABA- (or GSH) HERMES using the identical fitting routine. Metabolite levels from 
two-recombination fitting of HERMES data were then compared separately to metabolite levels from GABA- and 
GSH-edited MEGA-PRESS, respectively, using a Mann-Whitney U test. 
Subsequently, HERMES data were quantified by fitting to all four Hadamard re-combinations, namely sum 
(A+B+C+D), zero (-A+B-C+D), GSH (-A-B+C+D) and GABA (A-B-C+D) spectra. Metabolite levels from HERMES were 
compared separately to those obtained from fitting to sum and difference spectra of GABA- and GSH-edited 




To compare reproducibility’s for the different sequences, three subjects were scanned three times using all three 
sequences, namely GABA-edited MEGA-PRESS, GSH-edited MEGA-PRESS, and HERMES. Data were processed 
using the fitting routine and reproducibility assessed using coefficients of variation (CVs). Un-edited 
spectroscopy (such as PRESS) typically gives good reproducibility (over 95%) for total N-acetylaspartate (NAA + 
NAAG = tNAA), total creatine (Cr + PCr = tCr), choline containing compounds (GPC + PCh = Cho), and myo-inositol 
(Ins). The signals of glutamate and glutamine are also detectable with un-edited spectroscopy, but typically give 
less reproducible results than tNAA, tCr, Cho, and Ins.  
 
4.3.4 Comparison of simultaneous and multiple independent fittings  
 
To evaluate the potential benefit of our simultaneous fitting approach compared to multiple independent 
fittings, both procedures were applied to HERCULES data that had been previously acquired from two 3 × 3 × 3 
cm3 voxels (one white-matter-rich (WM) voxel in the centrum semiovale, and one grey-matter-rich (GM) voxel 
over the cingulate cortex) in 10 healthy adult participants (5 male, mean age 29.3 ± 2.9 yr) using a 32-channel 
head coil on the 3T Philips Achieva MRI at John’s Hopkins University (Oeltzschner et al. 2019). Acquisition 
parameters were TE/TR 80/2000 ms; 20-ms editing pulses; 320 averages (i.e. 80 averages for each sub-
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experiment), 2048 data points; 2 kHz spectral width; and VAPOR water suppression. A non-water-suppressed 
reference scan (16 averages) was also acquired in each voxel. 
Analysis of Variance (ANOVA) was used to compare metabolite levels obtained from simultaneous fitting to 





5.1 Phantom testing 
 
Scans with phantom set #2 yielded low SNR, presumably due to the small voxel size imposed by the phantom’s 
design, possible signal contamination from the plastic container, and poor shimming. Phantom set #3 was 
therefore used in all subsequent experiments aimed at validating the processing algorithm. 
The phantom was at 5 degrees Celsius when scanned. Manual shimming yielded a FWHM for the water peak of 
2.0 Hz immediately prior to the start of the edited MRS protocol. The frequency of the editing pulses was not 
adjusted to account for chemical shift changes resulting from the phantom being at a low temperature.  
Figure 5-1 shows the GABA (left) and GSH (right) difference spectra for Phantom #3 obtained from HERMES and 
GABA- or GSH-edited MEGA-PRESS acquisitions, respectively. Simulated spectra for GABA and GSH are also 
shown for both (left) GABA- and (right) GSH-edited MEGA-PRESS. Figure 5-2 shows a comparison of actual 
metabolite levels to estimates obtained for each acquisition using the simultaneous linear combination model. 
During fitting the frequency was manually shifted by 150 Hz. While metabolite level estimates of tNAA from all 
acquisitions were similar to actual values, HERMES yielded the most reliable estimate of total choline levels. 
Estimates for creatine from all three acquisitions were about 25% lower than actual levels, and for GSH and 





Figure 5-1 – GABA (left) and GSH (right) difference spectra (plotted in solid lines) for phantom #3 from HERMES and (left) 
GABA- or (right) GSH-edited MEGA-PRESS acquisitions, respectively. (Left) The GABA difference spectrum is obtained using 
(A-B-C+D) for HERMES data and EDIT ON – EDIT OFF for GABA-edited MEGA-PRESS. (Right) The GSH difference spectrum is 
given by (-A-B+C+D) for HERMES data and EDIT ON – EDIT OFF for GSH-edited MEGA-PRESS. The dotted lines show simulated 




Figure 5-2 - Bar graph comparing the known metabolite concentrations in phantom #3 to the metabolite level estimates 







5.2 In vivo testing 
 
In vivo scans were performed over 9 scanning sessions and are summarised in Table 5-1. The first 6 scans (S01-
S06) were all unsuccessful due to an incorrect B1 power setting and sequence error. Data from a further 3 scans 
(G01, G06 and G12) could not be used. As such, data acquired in 15 participants were used to validate the 
sequence and quantification tool. 
 
Table 5-1 – Scanning record 
Code Weight  Age  Sex Height Repeats Comment 
Valid/invalid 
data 
S01 47,5 26 Female 152 0 
B1 power setting incorrect. 
Sequence pulse file prior to 12 
July patch 
Invalid 
S02 56,5 28 Male 174,5 0 Invalid 
S03 60,4 26 Female 173 0 Invalid 
S04 51,1 24 Male 169 0 Invalid 
S05 68,3 27 Male 174 0 Invalid 
S06 55 28 Female 168 0 Invalid 
G01 80 26 Male 186 0 
Significant field 
inhomogeneity. Scans 
followed DTI scans. Potential 
coil heating issue. Invalid 
G02 64 24 Male 162 0  Valid 
G03 102 24 Female 178 0  Valid 
G04 54 24 Female 177 0  Valid 
G05 79 24 Male 189 0  Valid 
G06 47,5 26 Female 152 2 
Subject requested to be 
removed from the study Invalid 
G07 66 24 Female 174 2  Valid 
G08 65 23 Female 171 2  Valid 
G09 55 21 Female 169 0  Valid 
G10 71 26 Male 170 2  Valid 
G11 79 24 Male 180 0  Valid 
G12 82 29 Male  188 0 
Subject became 
claustrophobic. Scan was not 
completed. Invalid 
G13 61 27 Female 177 0  Valid 
G14 92 27 Male 179 0  Valid 
G15 57 29 Female 162 0  Valid 
G16 72 29 Male 180 0   Valid 
G17 49 26 Female  159 0   Valid 
G18 79 32 Male 177 0   Valid 
        
      Total number of scans 32 
      Number of valid scans  21 
      
Number of subjects providing 




Figures 5-3 to 5-5 present GABA- and GSH-edited MEGA-PRESS and HERMES data, respectively, acquired in the 
same subject (G04). Sub-plots A show the individual acquisitions, sub-plots B show the averages for each sub-
experiment, and sub-plots C (and D for HERMES) show the difference (or Hadamard recombined for HERMES) 
spectra. In sub-plots C (and D for HERMES), the edited peaks around 3 ppm have been highlighted. Notably, in 
this subject, the Hadamard recombined GABA and GSH spectra from HERMES (Figure 5-5 C and D) are 
comparable to the difference spectra obtained from the two separate GABA- and GSH-edited MEGA-PRESS 
acquisitions (Figures 5-3C and 5-4C). Figure 5-6 shows the HERMES GABA and GSH spectra and those from 
separate GABA- and GSH-edited MEGA-PRESS acquisitions averaged across all 15 participants. Figure 5-7 shows 
the parameter estimates of each metabolite obtained using our simultaneous linear combination modelling 




Figure 5-3 - Spectra from the GABA-edited MEGA-PRESS acquisition in subject G04. A shows all 320 acquisitions, B the 
averaged spectra for each sub-experiment, and C the difference spectrum with the edited GABA peak highlighted. Note that 
the spectrum in C was scaled to highlight the edited GABA peak at 3.01 ppm. 
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Figure 5-5 – Spectra from the HERMES acquisition in subject G04. A shows all 320 acquisitions, B the averaged spectra for 
each sub-experiment, C the Hadamard recombined spectrum for GABA, and D the Hadamard recombined spectrum for GSH. 
The GABA and GSH edited peaks are highlighted in C and D, respectively. The spectra in C and D were scaled to highlight the 
two edited peaks. 
Figure 5-4 – Spectra from the GSH-edited MEGA-PRESS acquisition in subject G04. A shows all 320 acquisitions, B the 
averaged spectra for each sub-experiment, and C the difference spectrum with the edited GSH peak highlighted. Note 




Figure 5-6 – GABA (left) and GSH (right) spectra from HERMES (A, C) and GABA- or GSH-edited MEGA-PRESS (B or D, 
respectively) averaged across all 15 participants. The grey shading shows the variance. 
 
 
Figure 5-7 – Results from the linear combination fitting of GABA-edited MEGA-PRESS data acquired in subject G04. The initial 
parameter estimates (x0 in lsqcurvefit) are shown on the left, and the final parameter estimates on the right. The model 
spectrum was corrected with a baseline spline. 
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As described previously, HERMES data were first analysed using fitting to only two re-combinations, namely sum 
and either GSH (-A-B+C+D) or GABA (A-B-C+D) difference spectra, to allow direct comparison with MEGA-PRESS 
data that are also fit simultaneously to only two combinations (sum and difference). Table 5-2 compares 
metabolite levels obtained from MEGA-PRESS and HERMES data when using identical simultaneous two-
combination fitting routines. Notably, mean concentrations across the 15 subjects obtained from HERMES and 
MEGA-PRESS data differed for about half the metabolites. Asc, GSH, NAAG, NAA, Scyllo, tCr, tCho, and tNAA 
levels did not differ significantly between GABA-edited MEGA-PRESS and HERMES, and for GSH-edited MEGA-
PRESS and HERMES, levels of Ins, Lac, NAAG, NAA, Scyllo, tCr, and tNAA were similar. 
 
 
Table 5-2 - Mean (and standard deviations) of absolute metabolite concentrations across 15 subjects. Fitting routine used 
only SUM and GABA- or GSH-difference spectra from both MEGA-PRESS and HERMES data. Since more than half the 






























Asc 1,9 (1,8) 2,7 (3,1) 0,803 3,3 (1,4) 1,7 (2,1) 0,008 
Asp 1,9 (0,7) 0,6 (0,4) <0.001 1,2 (0,6) 0,5 (0,4) <0.001 
GABA 5,5 (2,7) 4,2 (1,4) 0,018 0,0 (0,0) 4,0 (1,6) <0.001 
GSH 1,7 (1,2) 2,4 (1,0) 0,068 1,6 (0,5) 2,7 (0,9) <0.001 
Gln 1,9 (1,1) 1,1 (0,7) 0,046 0,1 (0,1) 1,0 (0,8) <0.001 
Glu 17,6 (7,5) 13,3 (4,7) 0,001 7,9 (1,6) 11,8 (4,4) <0.001 
Ins 13,0 (5,0) 10,4 (3,5) 0,004 9,2 (1,2) 10,2 (3,5) 0,481 
Lac 0,0 (0,0) 0,0 (0,0) 0,042 0,0 (0,1) 0,0 (0,0) 0,32 
NAAG 5,7 (1,8) 5,2 (1,8) 0,32 5,0 (0,9) 4,5 (1,6) 0,051 
NAA 19,1 (7,4) 17,1 (6,0) 0,481 15,6 (2,9) 16,9 (5,9) 0,455 
Scyllo 1,8 (2,6) 0,7 (1,0) 0,229 0,5 (0,7) 0,8 (1,1) 0,455 
tCr 12,9 (4,9) 11,6 (3,7) 0,431 10,7 (1,6) 11,7 (3,7) 0,561 
tCho 5,3 (2,4) 5,3 (1,8) 0,591 2,3 (0,5) 2,9 (0,7) 0,013 
tNAA 24,8 (9,1) 22,2 (7,6) 0,300 20,5 (3,6) 21,4 (7,4) 0,678 
* Bold denotes significance at p <0.05 
 
Subsequently, HERMES data were quantified by fitting to all four Hadamard re-combinations. All least squares 
optimisations stopped due to convergence and iteration limits were not reached. Data from repeat scans were 
not included when calculating mean metabolite levels. Figure 5-8 shows in a single subject how metabolite levels 
obtained from HERMES data compare to those obtained from GABA- and GSH-edited MEGA-PRESS. Table 5-3 
and Figure 5-9 compares mean metabolite levels across all 15 participants obtained from HERMES data using 
simultaneous fitting to four spectral re-combinations to metabolite levels obtained from simultaneous two-
combination fitting of GABA- and GSH-edited MEGA-PRESS data, respectively. Except for Asc, GSH, Lac, and NAA 
(for which levels were similar), levels for all other metabolites obtained from HERMES data were significantly 
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lower than those from GABA-edited MEGA-PRESS. Levels from GSH-edited MEGA-PRESS and HERMES were 
similar for Ins, NAAG, NAA, Scyllo, tCr, tCho and tNAA, but differed for all other metabolites.   
 
Figure 5-8 – Comparison of metabolite levels obtained in a single subject (G04) from simultaneous linear combination fitting 
of HERMES (red), GABA- (blue) and GSH-edited (green) MEGA-PRESS data. 
 
 
Table 5-3 - Mean (and standard deviations) of absolute metabolite concentrations across 15 subjects. For HERMES data, the 
fitting routine used all four re-combination spectra (SUM, zero, GSH, and GABA). For MEGA-PRESS data,  two re-combinations 
(SUM and difference) were used in the fitting routine. Since more than half the metabolites and fitting combination datasets 











p-values from  

















Asc 1,9 (1,8) 3,3 (1,4) 2,2 (1,2) 0,678 0,020 
Asp 1,9 (0,7) 1,2 (0,6) 0,6 (0,3) <0,001 0,001 
GABA 5,5 (2,7) 0,0 (0,0) 3,6 (0,6) <0,001 <0,001 
GSH 1,7 (1,2) 1,6 (0,5) 1,9 (0,6) 0,340 0,028 
Gln 1,9 (1,1) 0,1 (0,1) 0,9 (0,4) 0,002 <0,001 
Glu 17,6 (7,5) 7,9 (1,6) 11,6 (1,0) <0,001 <0,001 
Ins 13,0 (5,0) 9,2 (1,2) 8,8 (0,7) <0,001 0,561 
Lac 0,0 (0,0) 0,0 (0,1) 0,0 (0,0) 0,074 0,034 
NAAG 5,7 (1,8) 5,0 (0,9) 4,4 (0,6) 0,010 0,074 
NAA 19,1 (7,4) 15,6 (2,9) 15,0 (1,2) 0,106 0,901 
Scyllo 1,8 (2,6) 0,5 (0,7) 0,3 (0,5) 0,018 0,407 
tCr 12,9 (4,9) 10,7 (1,6) 10,1 (0,6) 0,023 0,089 
tCho 5,3 (2,4) 2,3 (0,5) 2,2 (0,5) <0,001 0,507 
tNAA 24,8 (9,1) 20,5 (3,6) 19,3 (1,3) 0,038 0,340 
* Bold denotes significance at p <0.05 
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Figure 5-9 – Comparison of mean metabolite levels in 15 participants (not including data from repeat scans) obtained from 
linear combination fitting of HERMES (red), GABA- (blue) and GSH-edited (green) MEGA-PRESS data.  
 
Despite absolute agreement being poor for most metabolites, levels from GABA-edited MEGA-PRESS and 
HERMES showed moderate correlation (Spearman correlation: 0.42 - 0.79) for all metabolites except three (Asp, 
Gln and Lac), and moderate consistency (ICC: 0.45 – 0.76) for all metabolites except 5 (Asp, Gln, Lac, Glu & Ins) 
(Table 5-4). For GSH-edited MEGA-PRESS and HERMES, correlation was moderate (>0.39) to strong (<0.94), and 
consistency moderate (ICC: 0.44 – 0.76), for all metabolites except GABA. Figure 5-10 shows how the coefficients 
of variation (CVs) across the 15 participants compared for each metabolite for the three different acquisitions.  
 
Table 5-4 – Spearman’s rank and Intraclass correlation coefficients (and p-value) of metabolite levels obtained from MEGA-























Asc 0,64 (0,013) 0,69 (0,004) 0,59 (0,022) 0,58 (0,022) 
Asp 0,17 (0,541) 0,24 (0,399) 0,86 (<0.001) 0,76 (0,001) 
GABA 0,42 (0,119) 0,69 (0,005) 0,18 (0,524) -0,10 (0,733) 
GSH 0,53 (0,044) 0,73 (0,002) 0,49 (0,067) 0,61 (0,016) 
Gln 0,27 (0,333) 0,10 (0,716) 0,59 (0,022) 0,68 (0,005) 
Glu 0,50 (0,062) 0,15 (0,59) 0,74 (0,003) 0,64 (0,011) 
Ins 0,51 (0,056) 0,28 (0,321) 0,57 (0,029) 0,44 (0,1) 
Lac -0,11 (0,705) -0,11 (0,688) 0,39 (0,148) 0,53 (0,041) 
NAAG 0,74 (0,002) 0,61 (0,016) 0,83 (<0.001) 0,62 (0,015) 
NAA 0,79 (0,001) 0,48 (0,073) 0,94 (<0.001) 0,75 (0,001) 
Scyllo 0,58 (0,026) 0,45 (0,09) 0,55 (0,035) 0,69 (0,004) 
tCr 0,75 (0,002) 0,76 (0,001) 0,81 (<0.001) 0,54 (0,04) 
tCho 0,55 (0,038) 0,48 (0,069) 0,74 (0,003) 0,65 (0,009) 
tNAA 0,78 (0,001) 0,62 (0,013) 0,93 (<0.001) 0,72 (0,002) 




Figure 5-10 - Coefficients of variation (CVs)  of the metabolite levels across the 15 subjects for each of the three acquisitions: 
HERMES, GABA-edited MEGA-PRESS, and GSH-edited MEGA-PRESS. Coloured dots are used where CVs are over 150%. 
 
The metabolite concentrations obtained from the HERMES data had the lowest CVs for GABA, Gln, Glu, Ins, 
NAAG, NAA, tCr, tCho, and tNAA. Metabolite concentrations from GABA-edited MEGA-PRESS had the lowest CV 






5.3 Reproducibility  
 
Figure 5-11 shows good agreement between metabolite levels obtained in three subjects from HERMES 
acquisitions in three different scanning sessions. Greater variance across scanning sessions were evident for 
metabolite levels obtained from GABA-edited MEGA-PRESS acquisitions in subjects G08 and G10 (Figure 5-12).  
Coefficients of variation within and across subjects are compared for 8 metabolites in Table 5-5 and Figure 5-
13 for GABA- and GSH-edited MEGA-PRESS and HERMES acquisitions.  
 
Figure 5-11 – Comparison in three subjects of metabolite concentrations obtained from HERMES acquisitions performed in 








Figure 5-12 – Box and whisker plots for three subjects showing how metabolite levels vary across three scanning sessions for 
HERMES, and GABA- and GSH-edited MEGA-PRESS acquisitions, respectively.  
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Table 5-5 - Coefficients of variation within and across subjects of tNAA, tCr, tCho, Ins, Glu, Gln, GABA, and GSH levels obtained 
in three different scanning sessions from HERMES, GABA- and GSH-edited MEGA-PRESS acquisitions, respectively. 
  Coefficients of variation of metabolite levels obtained with each sequence in 3 
separate scanning sessions (%) 
Sequence Subject tNAA tCr tCho Ins Glu Gln GABA  GSH 
HERMES 
G07 10.6 4.7 6.5 1.1 6.0 10.8 17.1 10.4 
G08 6.5 4.4 2.1 3.3 1.6 0.0 7.2 8.5 
G10 1.3 2.5 27.5 5.2 4.7 53.8 8.6 25.3 
Across 
subjects 





G07 9.6 3.5 5.0 2.0 6.0 24.7 16.1 3.3 
G08 13.8 11.3 5.4 5.3 10.4 30.7 20.8 22.3 
G10 22.5 23.3 7.4 19.8 1.5 9.5 17.4 24.1 
Across 
subjects 





G07 10.9 10.6 34.4 5.5 2.1 undef undef 61.4 
G08 4.9 3.3 30.9 1.1 2.9 undef undef 28.9 
G10 1.3 2.0 3.1 2.4 1.5 undef undef 16.7 
Across 
subjects 





Figure 5-13 – Comparison for different metabolites of coefficients of variation across subjects and scanning sessions for 
































HERMES GABA MEGA-PRESS GSH MEGA-PRESS
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5.4 Comparison of simultaneous and multiple independent fittings 
 
Figure 5-14 demonstrates the four fitting algorithms that are being compared, namely simultaneous fitting to 
concatenated sum, GSH, GABA and zero spectra (top row), or separate fittings to either the SUM, GSH difference 
or GABA difference spectra, respectively. Table 5-6 shows metabolite ratios relative to total creatine estimated 
using each of the different fitting routines from HERCULES data acquired in 10 subjects in two voxels – one white 
matter (WM) rich voxel in the centrum semiovale and one grey matter (GM) rich voxel positioned over the 
cingulate cortex. Figures 5-15 and Figure 5-16 are box and whisker plots showing the metabolite levels obtained 
using each fitting approach for the grey- and white matter rich voxels, respectively. Figures 5-17 and 5-18 show 
the coefficients of variation of the metabolite levels for each fitting approach in the grey matter and white 
matter rich voxels, respectively.  
 





Table 5-6 - Mean metabolite concentration values relative to tCr for a grey matter rich (Cingulate Cortex) voxel (top) and a 
white matter rich (Centrum Semiovale) voxel (bottom) are shown. The last column shows ANOVA p values with values less 
than 0.05 highlighted in green. Since fewer than 15% of the datasets had skewness above or below 2 or -2,  Analysis of 
Variance (ANOVA) was used.  
Metabolite  Simultaneous 
spectra fit (Stdev) 








Grey Matter rich voxel (Cigulate Cortex) 
Asc 0.07 (0.12) 0.01 (0.04) 2.53 (1.96) 0.13 (0.19) <0,001 
Asp 0.10 (0.04) 0.04 (0.06) 0.78 (0.61) 0.34 (0.22) <0,001 
GABA 0.31 (0.06) 0.34 (0.06) 0.31 (0.29) 0.07 (0.03) 0,001 
GSH 0.25 (0.02) 0.26 (0.04) 0.20 (0.16) 0.11 (0.09) 0,005 
Gln 0.15 (0.05) 0.20 (0.07) 0.17 (0.13) 0.20 (0.53) 0,973 
Glu 1.19 (0.10) 1.08 (0.18) 1.28 (1.02) 0.67 (1.17) 0,332 
Ins 0.91 (0.08) 0.87 (0.08) 3.13 (3.94) 1.37 (1.15) 0,060 
Lac 0.20 (0.12) 0.40 (0.25) 0.83 (1.96) 0.11 (0.10) 0,379 
NAAG 0.26 (0.08) 0.30 (0.10) 0.24 (0.18) 0.19 (0.11) 0,246 
NAA 1.57 (0.13) 1.47 (0.15) 1.92 (1.10) 1.49 (0.84) 0,462 
Scyllo 0.19 (0.14) 0.15 (0.13) 16.70 (47.5) 34.9 (34.8) 0,037 
tCho 0.36 (0.09) 0.41 (0.13) 1.78 (1.42) 0.23 (0.18) <0,001 
tNAA 1.83 (0.10) 1.77 (0.13) 2.15 (1.21) 1.68 (0.91) 0,534 
White Matter rich voxel (Centrum Semiovale) 
Asc 0.07 (0.11) 0.05 (0.12) 1.38 (1.36) 0.11 (0.18) <0,001 
Asp 0.04 (0.05) 0.07 (0.12) 0.72 (0.76) 0.25 (0.23) 0,002 
GABA 0.27 (0.03) 0.37 (0.06) 0.22 (0.19) 0.08 (0.04) <0,001 
GSH 0.22 (0.04) 0.22 (0.05) 0.16 (0.15) 0.44 (0.70) 0,329 
Gln 0.18 (0.06) 0.30 (0.16) 0.18 (0.17) 0.79 (1.41) 0,193 
Glu 1.01 (0.24) 0.98 (0.27) 1.00 (0.91) 0.77 (1.53) 0,928 
Ins 0.81 (0.16) 0.79 (0.15) 3.72 (4.00) 0.77 (0.55) 0,004 
Lac 0.10 (0.03) 0.18 (0.09) 0.15 (0.31) 0.07 (0.05) 0,485 
NAAG 0.60 (0.13) 0.59 (0.13) 0.56 (0.25) 0.49 (0.32) 0,698 
NAA 1.67 (0.12) 1.58 (0.13) 1.99 (1.61) 1.79 (1.89) 0,896 
Scyllo 0.22 (0.22) 0.20 (0.25) 22.7 (50.6) 5.74 (7.30) 0,175 
tCho 0.47 (0.10) 0.49 (0.12) 3.39 (5.34) 0.27 (0.21) 0,038 
tNAA 2.27 (0.16) 2.17 (0.15) 2.55 (1.82) 2.28 (2.17) 0,942 




Figure 5-15 – Metabolite concentrations relative to total creatine in 10 subjects from HERCULES data in a grey matter rich 
voxel (cingulate cortex). Plot compares quantification by fitting all data simultaneously, and fitting to just the SUM, GABA 
or GSH re-combinations, respectively.  
 
 
Figure 5-16 - Metabolite concentrations relative to total creatine in 10 subjects from HERCULES data in a white matter rich 
voxel (centrum semiovale). Plot compares quantification by fitting all data simultaneously, and fitting to just SUM, GABA or 




Figure 5-17 – Comparison of coefficients of variation of metabolite ratios relative to total creatine in a grey matter rich 
voxel (cingulate cortex) in 10 subjects obtained from simultaneous modelling of the HERUCLES data, and separate 
modelling to SUM, GABA, or GSH difference  spectra.  
 
 
Figure 5-18 - Comparison of coefficients of variation of metabolite ratios relative to total creatine in a white matter rich 
voxel (centrum semiovale) in 10 subjects obtained from simultaneous modelling of the HERUCLES data, and separate 






6.1 HERMES Sequence Implementation 
 
A feature of the current HERMES implementation, is the ability to acquire MEGA-PRESS data by de-selecting the 
check-box for a second editing pulse in the ‘special’ card on the user interface. This MEGA-PRESS acquisition 
differs from the standard Siemens WIP in that it uses standardised RF pulse shapes and altered sequence timing 
(similar to that of the Philips HERMES implementation), thereby facilitating direct comparison of HERMES and 
MEGA-PRESS data, as well as between vendor platforms.  
Phantom Testing 
Phantom testing demonstrated that HERMES and the two (GABA- and GSH-edited) MEGA-PRESS acquisitions 
are able to accurately quantify total NAA. HERMES provided the most reliable estimate of total choline, with 
levels from GABA- and GSH-edited MEGA-PRESS being too high by about 25% and 12%, respectively. Data from 
all three acquisitions underestimated creatine levels by roughly 25%  and failed to accurately quantify GABA or 
GSH levels, which were more than 50% lower than actual levels. Additionally, GABA-edited MEGA-PRESS 
incorrectly detected low levels of Asc, Ins and Scyllo, while HERMES and GSH-edited MEGA-PRESS incorrectly 
detected low levels of Asc only.  
The low levels of GABA and GSH may, in part, be due to poor editing efficiency resulting from temperature-
related frequency shifts as the phantoms were at 5 degree Celsius when scanned. Editing efficiency refers to the 
percentage of signal that is correctly inverted in the difference spectra. Any temperature-related frequency shift 
would cause the coupled spin systems to not be completely inverted. Poor editing efficiency can be accounted 
for retrospectively by measuring the frequency shift and calculating the loss of editing efficiency from the pulse 
profile. The editing efficiency for a 5 Hz shift would, for example, be roughly 50% (Figure 4-6). Prospective 
correction is also possible by shifting the frequency of the editing pulses before acquisition, following an initial 
unedited calibration scan (PRESS SVS) to determine the frequency shift. Since prospective adjustment will not 
correct for efficiency loss due to field inhomogeneity and drift, retrospective scaling adjustment should still be 
performed. The absence of editing efficiency correction in the present work may contribute to underestimation 
of GABA and GSH levels. 
Despite absolute agreement of GABA and GSH levels being poor, line shapes of the GABA- and GSH-difference 
spectra obtained from HERMES and MEGA-PRESS acquisitions were comparable and features from the relevant 
basis spectra were clearly visible, albeit shifted by roughly 0.2 ppm to the right. This shift is presumably also due 
to the phantom being at lower temperature than in vivo tissue. Although LCModel allows for each individual 
metabolite basis spectrum to be shifted independently, our simultaneous linear combination fitting routine that 
only applies a single shift to all the basis spectra yielded good fits and signal isolation. 
 
In vivo Testing 
In vivo data demonstrated successful GABA and GSH editing with both the MEGA-PRESS and HERMES sequences 
(Figures 5-3 to 5-6), and comparable line shapes across 15 participants. Consistent with other in vivo studies, we 
observe a single rounded peak in the GABA difference spectra at 3 ppm rather than the ‘pseudo doublet’ seen 
on simulations and phantom data (Mikkelsen et al. 2017), while the co-edited Glx doublet peaks of glutamine 
and glutathione are evident at 3.75 ppm. Overall, our GABA difference spectra from both the HERMES and 
MEGA-PRESS acquisitions closely match typical GE and Philips GABA spectra (Mikkelsen et al. 2017), while the 
characteristic ‘bump’ normally seen in Siemens MEGA-PRESS data to the left of the GABA peak at 3 ppm 
(Mikkelsen et al. 2017) is less visible, indicating that its origin may be the RF pulse shape and timing used in the 
Siemens WIP rather than being hardware-related. The very large negative peak at 1.9 ppm observed in both the 
HERMES and MEGA-PRESS spectra is caused directly by the editing pulse rather than through coupling as with 
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the 3 ppm peak. The intensity range shown by the grey shading was generated from the maximum and minimum 
intensities at each frequency across subjects. The large intensity variation seen at and to the right of the negative 
peak at 1.9 ppm may be due to field drift, causing the centre frequency and bandwidth of the editing pulse to 
shift thereby creating subtraction differences between acquisitions.   
With regards the GSH difference spectra in Figure 5-6,  MEGA-PRESS shows a more pronounced peak at 2 ppm 
than HERMES data. This peak could either be a subtraction artefact from the NAA signal, or a co-edited GABA 
signal from the 2.283 or 1.889 ppm GABA peaks. However, the latter is unlikely, since those two peaks are 
coupled to the 1.889 and 3.012 ppm spins, respectively, neither of which will be edited by the 4.56 ppm editing 
pulse applied in the GSH-edited MEGA-PRESS sequence. Additionally, this peak is located closer to 2 ppm and 
shows substantial inter-subject variation, indicating that it is more likely an NAA subtraction artefact. It is not 
clear why this peak is more pronounced in MEGA-PRESS than HERMES data. Notably, the GSH edited peak at 
2.995 ppm appears similarly in the MEGA-PRESS and HERMES GSH difference spectra. Another noteworthy 
feature is that the inter-subject variance of the GSH difference spectra (for both HERMES and MEGA-PRESS) is 
greater than the variance observed in the GABA difference spectra. This is particularly noticeable at frequencies 
above 3 ppm (left of the 3 ppm GSH peak), and may, in part, be due to subtraction artefacts from the editing 
pulse at 4.56 ppm (similar to the variance observed around the 1.9 ppm editing pulse frequency in the GABA 
difference spectra). Another contributing factor may be sidebands resulting from incomplete water suppression 
as shown in Figure 2-7 (de Graaf 2007). Since the editing pulses applied in the edit-ON measurements may have 
a water suppression effect, a greater portion of the variance observed in the difference spectra is likely from the 
edit-OFF measurements.  
Using simultaneous fitting to two re-combinations for MEGA-PRESS and HERMES data, quantification values 
from GABA-edited spectra differed for 6 of 14 metabolites, and for 7 of 14 metabolites for GSH-edited spectra. 
Simultaneous fitting to four re-combinations for HERMES yielded quantification values that were significantly 
different from GABA-edited MEGA-PRESS levels for 10 of 14 metabolites, and from GSH-edited MEGA-PRESS 
levels for 7 of 14 metabolites. Notably, GABA levels from GABA-edited MEGA-PRESS and HERMES differed 
significantly,  as well as GSH levels from GSH-edited MEGA-PRESS and HERMES. These findings suggest that four 
re-combination fitting does not improve quantification agreement between MEGA-PRESS and HERMES data. A 
limitation of the current study is that we do not have actual metabolite levels to determine which method is 
most accurate. At most, we are able to conclude that the three acquisitions yield largely different results, 
irrespective of the fitting routine. Four re-combination fitting of HERMES data did, however, yield lower CVs 
across 15 subjects than the two MEGA-PRESS acquisitions for 9 of 14 metabolites, suggesting that this method 
might be most reliable.  
In a study with GABA MEGA-PRESS data from 25 research sites and a total of 284 volunteers the cohort wide 
coefficient of variation for GABA+ was 10%, and for macromolecule suppressed quantification it was 29% 
(Mikkelsen et al. 2018). The term GABA+ refers to GABA quantification where macromolecule suppression has 
not been applied (as is the case in the present study also). Comparatively this research found CV values of 50% 
and 17% for GABA(+) using MEGA-PRESS and HERMES, respectively.  
Concentrations of tNAA and tCr in the brain typically range from 10.9 – 13 and  5.1 – 10.6 mmols/kgww, 
respectively, while the tCho concentration in the brain is roughly 1.6 mmols/kgww (Govindaraju et al. 2000). 
Across all participants, all three our acquisitions yielded substantially higher levels for tNAA and tCho, and levels 
of tCr at the upper limit. Levels obtained for Asc and Ins from all three acquisitions were higher than typical in 
vivo concentrations (see Table 4-2), while only levels from GABA-edited MEGA-PRESS were higher than typical 
concentrations for Asp, Glu and Scyllo. All three sequences yielded Gln and Lac levels that were lower than 
typical brain concentrations.  
Of specific relevance to this work is the accuracy of the edited GABA and GSH concentration estimates. Typical 
GABA and GSH concentrations in the brain are 1.3 – 1.9 and 2 mmols/kgww, respectively. HERMES and GABA-
edited MEGA-PRESS yielded GABA levels that were roughly two and three times higher, respectively, while GSH-
edited MEGA-PRESS and HERMES both yielded GSH levels similar to the expected value.  
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Despite absolute agreement being poor, the fact that metabolite levels from the different acquisitions were 
moderately correlated increases confidence that one might be able to distinguish group differences in study 
populations. 
GABA-edited MEGA-PRESS demonstrated poorer reproducibility than GSH-edited MEGA-PRESS and HERMES 
across scanning sessions in two of three participants who each completed three scanning sessions.  Across 
scanning sessions and participants, CVs from HERMES were lowest for 4 of the 8 metabolites that were 
compared (tCr, Ins, GABA and GSH). Within-subject CVs for GABA ranged from 7.2 to 17.1%, and from 8.5 to 
25.3% for GSH. GABA-edited MEGA-PRESS yielded the lowest CVs for tCho and Gln, and GSH-edited MEGA-PRESS 
for tNAA and Glu. Although GABA MEGA-PRESS had the highest CVs for 4 of the 8 metabolites (tNAA, tCr, Ins 
and Glu), CVs for Gln, GABA and GSH were similar to those from HERMES. Specifically, within-subject CVs for 
GABA from GABA-edited MEGA-PRESS ranged from 16.1 to 20.8%, and for GSH from 3.3 to 24.1%. Within-subject 
CVs of GSH from GSH-edited MEGA-PRESS ranged from 16.7 - 61.4%. Notably, Gln and GABA levels were 
undetectable on the GSH-edited MEGA-PRESS data, yielding undefined CVs. CVs for GABA from our HERMES and 
GABA MEGA-PRESS acquisitions were of the same order as reproducibilities reported in the 11 studies 
summarised in Table 3-1, where test-retest CVs for GABA from GABA MEGA-PRESS ranged from 0.2 to 16.2%. 
Using universal pulses, Saleh et al. (2019) reported within-subject CVs for GABA across different scanners of 3% 
using both MEGA-PRESS and HERMES. For GSH, Wijtenburg et al. (2019) reported CVs between two scanning 
sessions using MEGA-PRESS of 13.5%, while CVs using PRESS, PR-STEAM and SPECIAL were lower at 5.8%, 5.4% 
and 8%, respectively. In 2 of 3 subjects, CVs for GSH using HERMES were comparable, and in 1 of 3 subjects using 
GABA MEGA-PRESS. All other acquisitions yielded higher within-subject CVs for GSH.  
 
6.2 Simultaneous Modelling Technique   
 
Concentrations relative to tCr from simultaneous and three separate independent fittings agreed for 7 of 13 
metabolites in a grey matter rich voxel, and 8 of 13 metabolites in a white matter rich voxel.  In the grey matter 
rich voxel, the simultaneous fitting routine yielded the lowest CVs for all metabolites except Asc and Gln, with 
the CV for Gln being comparable to the lowest CV obtained from fitting to the SUM spectrum only. In the white 
matter rich voxel, CVs from simultaneous fitting were lowest for all metabolites except Asc and Asp. These 





The fitting routine failed to correct frequency shifts that may have affected editing efficiency. Inclusion of this 
may have improved quantification accuracy, specifically for GABA and GSH, which would be most severely 
impacted by such shifts. The basis sets also did not include spectra for macromolecule signal.  
The fact that no standard Siemens MEGA-PRESS WIP data were acquired also limits our ability to compare our 
results with findings from other studies, and performance of the newly implemented sequence with the current 
standard.  
Finally, acquisitions were always performed in the same order, namely GABA-edited MEGA-PRESS, followed by 
GSH-edited MEGA-PRESS, and finally, HERMES, which is not ideal. Failure to randomise the order of acquisitions 
could have resulted in systematic drift due to heating of the gradient coils and fatigue-related increases in 
subject motion towards the end of the scanning session. Although MRS is not gradient intensive and as such 
would likely not itself cause gradient coil heating, the T1 scan performed prior to the MRS acquisitions is gradient 
intensive and may have resulted in slight temperature-related frequency drifts. Any frequency shifts would 
result in reduced editing efficiency.   
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7 Conclusions and Recommendations for Future Work  
 
Although the HERMES sequence implemented on the Siemens platform as part of this project was able to 
successfully edit both GABA and GSH, and generate line shapes consistent with the work by Saleh et al. (Saleh 
et al. 2016), quantification accuracy was disappointing. In the phantom data, GSH and GABA concentrations 
were both roughly 50% of known levels. Since the actual concentrations in vivo were not known, we were not 
able to establish accuracy, but quantification agreement between the MEGA-PRESS and HERMES sequences was 
poor for most metabolites. Specifically, GABA levels were two to three times higher than expected values using 
both HERMES and GABA-edited MEGA-PRESS. Despite poor absolute agreement, concentrations from HERMES 
and MEGA-PRESS data were moderately correlated, and HERMES data showed lower coefficients of variation 
across subjects, suggesting that it may be more reliable.  HERMES was also more reproducible across scanning 
sessions and participants for more metabolites than GABA- or GSH-edited MEGA-PRESS.  
Our findings also show that simultaneous fitting using the sum and difference spectra produces lower 
coefficients of variation for most metabolites than fittings to sum and difference spectra separately.   
Future work might include:  
 Implementing HERMES (or other multiplexed edited spectroscopy sequences) on a cross platform 
development tool. This would help with standardisation and quick implementation between the 
scanners particularly as HERMES is improved.  
 Data acquisition from the same healthy subjects at different research sites with different scanner 
manufacturers. This would be the best way to compare the results from two scanners as physiological 
changes in metabolite levels of the same subject would be negligible.  
 Standardising the water suppression technique used on the Philips and Siemens implementations. The 
water suppression technique was not altered for this project and simply used the vendor native 
technique.  
 Corrections for editing efficiency should be incorporated into the fitting routine. This may improve the 
absolute quantification of the edited signals of GABA and GSH.  
 The basis sets should be simulated at more than a single point in the middle of the voxel. This will 
increase computational demands of the simulations.  
 Alternative modelling algorithms for the data processing technique should be considered. Least squares 
optimisation was not robust and required very careful handling of data in particular when switching 
between phantom and in vivo data. 
 The data processing technique could also undergo calibration using a more extensive set of phantom 
tests. This methodology would need to be carefully designed to make the code applicable to in vivo 
data.  
 Deep learning may be a strong candidate for consideration in future data processing techniques given 
the move to simultaneously considering more of the data. This data could ultimately be given to the 
deep learning algorithm in a less processed form, which would reduce the risk that the underlying signal 
is being modified in the pre-processing steps.  
 And finally, it is recommended that multiplexed editing sequences further differentiate the signal 
evolution by adding more sub-experiments that feature different editing pulses. These pulses could still 
be Hadamard encoded as a Hadamard matrix is defined for any arbitrary square matrix size. But it is 
the opinion of the author that even linearly spaced editing pulses varied from one acquisition to the 
next would improve signal isolation. The upper limit of this is the number of averages i.e. 320 different 
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